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AIDS  W Acquired immunodeficiency syndrome 
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Cryptosporidium is a genus of ubiquitous unicellular parasites belonging to the phylum 
Apicomplexa, whose members are parasites of the GI tract and airways. Cryptosporidium is the 
second largest cause of childhood diarrhoea in children under two and is associated with increased 
morbidity. Accompanying this is the low availability of treatment and lack of vaccines. The major 
barrier to developing effective treatment is the lack of reliable in vitro culture methods, in particular 
those which can support the complete growth of the parasite long term, while producing a high 
yield of oocysts. While numerous cell lines have been reported as maintaining the parasite, there 
remain no options for maintaining the parasite for longer than a week. The current cell line of 
choice, HCT-8, can only maintain infection for three days. Recently, our lab has successfully 
cultivated C. parvum in the oesophageal cancer derived cell line COLO-680N, and can maintain 
infection for over a week. Given the success of this cell line, a panel of cancer derived cell lines were 
grown in the presence of C. parvum for one week, with development assessed with fluorescent 
microscopy and PCR. Four cell lines were used to establish cultures for three weeks. The lung 
adenocarcinoma cell line, HCC4006, gave the highest oocyst yield of 5.8 x 105 oocysts per mL, a nine 
fold return on the initial inoculum. In addition, to tackle the issue of long term oocyst production in 
vitro, a simple, low cost bioreactor system using the COLO-680N cell line was established which 
produced infectious oocysts for 13 weeks. This method of oocyst production will be used to 
establish further cell lines as long term culture platforms. Further work aims to characterise these 
cell lines to establish factors which promote parasite development, and to further improve yield 












1.1 General Introduction 
Cryptosporidium is a genus of the phylum Apicomplexa, and are a group of small parasites which 
are known to invade cells of the GI tract (Tzipori et al. 2002) and the airways (Sponseller et al. 2014). 
From an evolutionary perspective, Cryptosporidium is hypothesised to present an early emerging 
group from the gregarines, and shares similarities with both them and the coccidia (Ryan et al. 
2016). Cryptosporidium is widely believed to be an obligate intracellular parasite, and occupies an 
intracellular but extracytoplasmic vacuole within the host  ?K ?,ĂƌĂet al. 2011), and has a multi-
stage life cycle typical of the Apicomplexans. These parasites are known to cause an acute, watery 
and non-bloody diarrhoeal disease in otherwise healthy adults, termed cryptosporidiosis. 
Cryptosporidiosis is particularly dangerous to the immunocompromised, where diarrhoea can 
become chronic and recovery is slow if at all, and infection can spread to secondary sites. 
Cryptosporidium can also cause chronic diarrhoea in children which can lead to growth stunting and 
delayed development (Checkley et al. 1998; Checkley et al. 2015). In severe cases, death from 
dehydration due to prolonged episodes of diarrhoea can also occur (Cacciò et al. 2014). There is 
only one FDA approved treatment, nitazoxanide, which shows little efficacy in the 
immunocompromised, and no vaccines currently exist (Checkley et al. 2015). In the developed 
world, waterborne outbreaks are common, with other common exposure routes being contact with 
infected livestock, individuals and food. C. parvum has the broadest host range of any 
Cryptosporidium species identified so far (Graczyk et al. 1997), and is common in livestock and 
humans . There is currently a major lack of methods which allow for in vitro culture for more than 
a few days (Karanis et al. 2011), which has hampered efforts to develop effective treatment and to 
understand much of its life cycle. This introduction will explore the disease cryptosporidiosis, the 
associated epidemiology, the cell biology of Cryptosporidium parvum and the current progress in 
developing in vitro culture, before describing the aims of this project. 
1.2 Cryptosporidiosis 
The infectious course of disease for C. parvum has been compared in several studies of otherwise 
healthy individuals. In otherwise healthy volunteers with no previous exposure to C. parvum a 
median infective dose was found to be 132 oocysts (Chappell et al. 1996), although other studies 
have found that 87 oocysts is sufficient to cause infection (Okhuysen et al. 1999). This low number 
of infectious oocysts means that a single shedding human or animal has huge infection potential. 
In terms of disease progression, incubation of oocysts had a 9 day incubation on average with mild 
disease lasting 3 days with unformed stool passing in otherwise healthy volunteers. These findings 
slightly contrast those found by Jokipii, which had a mean incubation period of 7.2 days and a mean 
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symptom duration of 12.2 days (Jokipii et al. 1986).  Differences likely arose from the sources of 
infection, as no distinction was made between species of Cryptosporidium in the Jokipii study. A 
similar analysis of otherwise healthy infected individuals found that in two groups of symptomatic 
infected individuals there was an average incubation period of 5 and 6.43 days (Chappell et al. 
1996). This study also found that while oocyst shedding does occur on consecutive days, certain 
stool samples on a given day may result in no oocysts being present in a given sample (Chappell et 
al. 1996). Isolates have varying degrees of infectivity, with the TAMU isolate having an ID50 of 9 
oocysts, while the UCP required 1042 oocysts (Okhuysen et al. 1999). In adults with pre-existing IgG 
against Cryptosporidium parvum there was a > 20 fold increase in the infectious dose required to 
cause an infection compared with adults with no previous exposure (Chappell et al. 1999). Infection 
did not appear to resolve quicker with previous exposure, although the number of symptomatic 
individuals was lower, suggesting previous exposure had some protective effects (Chappell et al. 
1999). Isolates also exhibit differing durations of diarrhoea (Okhuysen et al. 1999). Treating oocysts 
with Lactobacillus acidophilus and L. reuteri culture broth causes up to 81 % reduction in oocyst 
viability (Foster et al. 2003), suggesting that the host gut microbiota may have significant effects on 
disease progression and outcome. C. parvum has also been shown to have tumorigenic effects in a 
mouse model. An isolate of C. parvum from an immunosuppressed patient were used to 
experimentally infect dexamethasone suppressed and non-treated SCID mice. This led to neoplasm 
formation in all 18 of the tested mice (Certad et al. 2012). A study identifying the cause of death for 
calves in a Japanese dairy farm found that C. parvum and Giardia intestinalis co-infection was 
observed in one of the dead calves, and that C. parvum alone was enough to be lethal (Matsuura 
et al. 2017). Mortality in calves has also been observed by (Peeters et al. 1992), where experimental 
infections of newborn calves caused 3 of 5 calves to die. The Global Enteric Multicentre Study 
(GEMS) identified that infection with C. parvum is associated with increased mortality in children 
when compared to other causes of prolonged diarrhoea (Checkley et al. 2015). C. parvum shows 
increased mortality in numerous young animals and children, and there are much needed 
improvements to be made in the prevention, diagnosis, and treatment of this parasite. 
1.3 Epidemiology  
Cryptosporidium parvum is one of the most common etiological agents of cryptosporidiosis, along 
with Cryptosporidium hominis (Checkley et al. 2015). C. parvum has one of the most diverse ranges 
of host species among Cryptosporidium spp., being capable of infecting humans and several other 
mammalian species (Upton et al. 1985; Graczyk et al. 1997; Hunter et al. 2005). The developed 
world experiences seasonal outbreaks of cryptosporidiosis which are often linked to contaminated 
water exposure, with Cryptosporidium spp. being responsible for 60.3 % of protozoan waterborne 
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outbreaks between 2004 and 2010 (Efstratiou et al. 2017). The largest ever outbreak of a 
waterborne protozoan illness in the United States was attributed to C. parvum. The outbreak 
occurred in 1993 in Milwaukee and led to an estimated 403,000 individuals contracting 
cryptosporidiosis (Mac Kenzie et al. 1994) and an estimated 54 deaths (Hoxie et al. 1997). The 
Milwaukee outbreak was studied amongst children, and gave evidence that the southern water 
treatment plant was the source of the outbreak, due to a higher increase in anti-C. parvum IgG 
among children living in the southern region (McDonald et al. 2001). An earlier outbreak in Georgia, 
1987, first drew attention to the ability of C. parvum to contaminate regulation compliant water 
supplies, in particular its resistance to commonly used purification procedures such as bleaching 
and filtration (Hayes et al. 1989). Numerous waterborne, foodborne and zoonotic outbreaks have 
been reported (Table 1). Due to the wide host range of C. parvum, zoonotic exposure is another 
common infection route (Hunter et al. 2005; Graczyk et al. 1997), with younger children and animals 
being particularly at risk. One study of feral pigs in California found that 5 % of the 221 sampled 
pigs were shedding C. parvum oocysts, with younger pigs (A? 8 months old) and pigs from densely 
pig populated areas being the highest shedders (Atwill et al. 1997).  A genotyping study of European 
hedgehogs hospitalised in Brno-Country (Czech Republic) with enteric symptoms revealed C. 
parvum subtype IIdA18G1 to be present in all 10 affected juveniles (Hofmannová et al. 2016). In 
middle Egypt, 14.19 % of 458 buffalo calves shed oocysts; 1-15 day old buffalo calves were at a 
significantly higher risk of infection (El-Khodery et al. 2008). Asymptomatic shedding of C. parvum 
oocysts in house mice, wood mice and bank voles has been identified in a Warwickshire agricultural 
site, and presents a potential reservoir of infection for both man and domestic livestock (Chalmers 
et al. 1997). A genotyping study of Cryptosporidium spp. in the United Kingdom identified that C. 
parvum was identified in 61.5 % of 1,705 human faecal samples (Mclauchlin et al. 2000). This study 
also associated C. parvum with increased spring cases and had a higher case rate in non-travellers, 
while C. hominis was linked to disease as a result of travelling abroad. A later study covering 
outbreaks from 1985 - 2000 analysed 2414 human cases and found that C. parvum was identified 
in 56.1 % of patients, C. hominis was identified in 41.7 % of cases and both were identified in 0.9 % 
of cases (Leoni et al. 2006). Genotyping of isolates from AIDS patients in Switzerland, Kenya and the 
USA found that C. parvum was responsible for half of the Swiss cases and one of the six Kenyan 
cases (Morgan et al. 2000). Exposure through interaction with infected livestock and/or animal 
reservoirs is a well-known risk factor, and adequate hygiene measures need to be taken when 
dealing with livestock and potentially infected animals.  
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Cattle shed faeces insufficiently 
removed from public water 
supply 




Waterborne  Estimated 
403,000 cases, 
54 deaths  
Contamination of Southern water 
treatment plant from sewage 
outlet  
(Mac Kenzie et 
al. 1994; 
McDonald et al. 





Waterborne  516 Failure to remove oocysts in 





USA, 1993  




Waterborne  575 Contaminated public water 
supply, potentially from shedding 
cattle 
(Patel et al. 





Waterborne  345 Contaminated public water 
supply, likely contamination from 
upriver sewage works  
(Patel et al. 




Waterborne  126 Worn pipes allowed 
contamination of drinking water 
with waste water  




Waterborne  Estimated 800 
- 1000 
Insufficient removal of oocysts 






Waterborne  Estimated 154 Insufficient chlorine levels to kill 
oocysts in artificial lake  
(Cantey et al. 
2012) 
Washington 
D.C., USA, 1998 
Foodborne  92  Infected individual preparing raw 
food  




Foodborne 160 Contaminated cider, likely from 
shedding calf at cider farm 




Foodborne 12 Ozonation treatment of cider 





Foodborne 16 Unwashed contaminated parsley 




Japan, 2006  
Foodborne 4 Contaminated liver and/or Yukke  (Yoshida et al. 
2007) 
New York, USA, 
2000 
Zoonotic 7 Veterinary students exposed to 
shedding calves  




Zoonotic  6 Veterinary students in contact 
with infected new-born foals  
(Galuppi et al. 
2016) 
 
Outbreaks in the developed world are well documented, owing to the general access to higher 
accuracy methods and expertise in diagnosis (Checkley et al. 2015). In less developed countries, 
cryptosporidiosis has a far greater burden and impact on health. Otherwise healthy adults tend to 
suffer from a mild, self-limiting infection, whereas young children in less developed areas tend to 
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suffer from a greater disease burden of prolonged shedding. A cross sectional case study of children 
in Uganda found that cryptosporidiosis was associated with persistent diarrhoea, malnutrition 
(underweight, wasting, and stunting), unfavourable outcome of diarrhoea and death (Tumwine et 
al. 2003). Studies in children living in slums in Brazil found that cryptosporidiosis was both highly 
seasonal (occurring more commonly in the months with higher rainfall) and commonly occurred in 
young children (mean age of first infection 11.9 months) (Newman et al. 1999). The prolonged 
burden of disease in children has been observed in Peruvian children living in a shanty town in Lima. 
Young children between 0 and 5 months of age who were infected demonstrated an average deficit 
of height of 0.95 cm (Checkley et al. 1998). Children who were already stunted and suffered 
infection had a deficit of 1.05 cm compared to uninfected stunted children. This study highlights 
the prolonged effects that childhood infection with cryptosporidium can have. One study of 
children suffering from HIV/AIDS in Jos, Nigeria, found that none of the affected children were 
shedding C. parvum oocysts in stools, whereas oocysts were found in 3.8 % of the non-HIV/AIDS 
suffering control group (Banwat et al. 2004). The low prevalence of infection may be due to analysis 
of a single stool sample, as oocyst shedding does not always occur on consecutive days (Chappell 
et al. 1996). A recent study highlighted the high level of infection in Australian Aboriginal people, 
especially children under 4 years old, who had a nearly 20 times higher notification rate compared 
with non-Aboriginal Australians, with C. hominis being particularly prevalent (Ng-Hublin et al. 2017). 
Surveillance between 2012 and 2013 in Odisha (India) found a high incidence of oocyst shedding in 
cattle and found contamination in 37 % of ponds and 10 % of tube wells used for drinking water 
(Daniels et al. 2015). Finally, the global enteric multicentre study (GEMS) found that 
Cryptosporidium spp. were significantly associated with disease in toddlers aged 12-23 months 
regardless of the HIV/AIDS rate and associated with a significant mortality risk (Kotloff et al. 2013). 
Cryptosporidium infectious are hugely underreported, especially in rural and remote communities 
(Checkley et al. 2015), which likely corresponds to a huge underdiagnosed global health burden. 
Improvements in accessibility and diagnostic tools are needed, especially in lower income 
countries.  
1.4 Cell Biology  
Cryptosporidium parvum has a multi-stage life cycle typical of apicomplexans, all stages of which 
are completed in a single host organism (monoxenous). Structural studies have shown the general 
progression of the life cycle in vivo and in vitro, however molecular studies revealing the 
biochemical nature of the changes undergone by the parasite, including the triggers which cause 
progression through the life cycle, are lacking. The difficulties maintaining Cryptosporidium in vitro 
have slowed progress in this area. The life cycle of Cryptosporidium is a complex and multi-stage 
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process (Fig. 1). In brief, ingestion of an oocyst results in the release of four motile sporozoites in 
the small intestine, which invade the ileal cells and develop into trophozoites. These divide by 
merogeny to generate a type I meront containing six to eight type I merozoites, which when 
released continue this cycle by developing into trophozoites upon invasion. At some stage, certain 
type I merozoites will develop into type II meronts, which contain four type II merozoites. This 
begins the sexual stage of multiplication, as these merozoites develop into undifferentiated 
gametes upon cell invasion, and will then develop into macrogamonts or microgamonts, the latter 
of which produces microgametes. These fertilise the macrogamont and form a zygote, which will 
develop into one of two types of oocyst; thin walled, which will excyst and continue the replication 
cycle within the same host (auto-infection), and thick walled, which are shed into the environment 
(Fayer et al. 2008). Recent studies have suggested that there may be extracellular development 
(Hijjawi et al. 2004; Rosales et al. 2005; Aldeyarbi et al. 2016b; Aldeyarbi et al. 2016a; Aldeyarbi et 
al. 2016c), and that sexual stages can divide by binary fission (Borowski et al. 2010). Developing in 
vitro culture methods which can support the parasite for over two weeks is key to understanding 
the life cycle and the roles extracellular stages play.  




C. parvum oocysts are small, almost circular bodies measuring three to six µm in diameter. Within 
the oocyst are four sporozoites measuring 2 µm x 0.8 µm. Thick walled oocysts are extremely hardy 
and are resistant to many common disinfection methods, including 5.25 % sodium hypochlorite, 
and sodium hydroxide concentrations below 6 % (Barbee et al. 1999). Oocysts stored between 0 
and 20 °C are infectious for 24 weeks (Fayer et al. 1998), with inactivation being reported by heating 
at 72.4 °C for 1 minute or 64.2 °C for 5 minutes by (Fayer 1994), but only 15 seconds at 55 °C and 
60 °C and 5 seconds at 70 °C by (Fujino et al. 2002), indicating differences in inactivation times 
between strains. Oocysts can survive  W 15 °C for 24 hours and  W10 °C for 168 hours whilst retaining 
infectivity (Fayer et al. 1996). The highly resistant nature of the oocysts has been attributed to a 
complex lattice structure (Harris et al. 1999), a surface glycocalyx layer (Liu et al. 2010), 
carbohydrates, fatty acids and aliphatic hydrocarbons, hydrophobic proteins and an inner 
glycoprotein layer (Jenkins et al. 2010). Transcriptome analysis has revealed that oocysts are highly 
active in protein synthesis and translation, along with active proteasome and ubiquitin machinery 
(Zhang et al. 2012). As C. parvum lacks all de novo nutrient synthesis genes and becomes less 
Figure 1 - Outline of the Cryptosporidium parvum life cycle (Thompson et al. 2005). Ingested 
oocysts release sporozoites which invade the ileum, developing into trophozoites and type I 
meronts, containing type I merozoites. Released type I Merozoites can become trophozoites 
themselves or develop into type II meronts, which release type II merozoites, these develop 
into undifferentiated gamonts. Gamonts differentiate into macrogamonts or microgamonts, 
the latter produces microgametes which fertilise macrogamonts. Sporulation occurs within 
the host, releasing thick walled oocysts into the environment and thin walled oocysts, which 
auto-infect the same host organism. 
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infectious with age (Slifko et al. 1999), it is likely that the parasite relies on protein recycling and its 
own reserves of amylopectin to survive shifts in environmental conditions (Fayer 1994; Zhang et al. 
2012).  
Upon ingestion by a host, oocysts undergo a process known as excystation. This process involves 
an opening in the oocyst wall ? ƚĞƌŵĞĚ Ă  “suture ? ? ǁŚŝĐŚ ĞŶůĂƌŐĞƐprior to sporozoite release 
(Reduker 1985). The opening enables release of the sporozoites and subsequent invasion of 
intestinal epithelia (Reduker 1985). Sporozoites exhibit gliding motility common to other 
apicomplexan parasites, with helical motility patterns observed just prior to cell invasion (Wetzel 
et al. 2005).  Gliding motility relies on myosin motor activity, actin polymerisation and myosin light 
chain kinase phosphorylation of myosin (Forney et al. 1998). The motility trails are notably shorter 
than most other apicomplexans such as Toxoplasma and Plasmodium, generally being 2 to 3 times 
the sporozoite body length (Arrowood et al. 1991; Forney et al. 1998), with C. parvum sporozoites 
exhibiting three times faster movement than T. gondii tachyzoites (Wetzel et al. 2005). This may be 
attributed to oocyst adherence to the intestinal epithelia, as there is a short distance to cover for 
sporozoites to invade a host cell compared to Plasmodium and Toxoplasma, which migrate 
between several organs. 
The invasion process is mediated by multiple interactions between parasite proteins and the host 
plasma membrane (Arrowood et al. 1991; Doyle et al. 1993; Okhuysen et al. 1994; Petersen et al. 
1997; Barnes et al. 1998; Spano et al. 1998; Langer et al. 1999; Nesterenko et al. 1999; Cevallos et 
al. 2000; Langer et al. 2001; Pollok et al. 2003; Aguirre-García et al. 2007; Yao et al. 2007; Putignani 
et al. 2008; Singh et al. 2015). Through a still poorly understood process, invasion appears to be 
mediated by localisation of the apical complex to the anterior end of the sporozoite, followed by 
its discharge. Attachment and invasion occurs preferentially at 37 °C and at a pH of 7.4  W 7.6 (Chen 
et al. 1998; Huang et al. 2004), which are the conditions of the distal ileum (Evans et al. 1988), 
where infection is observed frequently. The sporozoite attaches to the plasma membrane of a host 
cell and is then enveloped (Chen et al. 1998), followed by transformation into a replicative 
trophozoite. Notable morphology changes are the parasite becoming rounded, and enlargement of 
the nucleus (Bonnin et al. 1999; Beyer et al. 2000). Internalisation of the parasite recruits vacuoles 
to the infected location, causing fusion and formation of the parasitophorous vacuole (Huang et al. 
2004). The transformation from invasive sporozoite to replicative trophozoite involves both host 
and parasite derived factors  ?K ?,ĂƌĂet al. 2011). Host derived signals, which cause this 
transformation have recently been identified; glycoproteins present in FBS, unidentified factors 
secreted by HCT-8 cells and Gal-GalNAc are all capable of inducing transformation into trophozoites 
(Edwinson et al. 2016). The localisation of Gal-GalNAc to the infection site (Nelson et al. 2006) is 
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likely key to allowing the parasite to become replicative. Sporozoites, which have been pre-treated 
with Gal-GalNAc, showed decreased ability to enter human colorectal adenocarcinoma cells (HCT-
8) and primary bovine intestinal cells (Hashim et al. 2006), perhaps due to the switch to 
trophozoites and subsequent loss of invasive cellular elements (Beyer et al. 2000). Trophozoite 
development is accompanied by ƚŚĞĨŽƌŵĂƚŝŽŶŽĨƚŚĞ  ‘ĨĞĞĚĞƌŽƌŐĂŶĞůůĞ ? ?ĂƚƵďĞŽƌƚƵŶŶĞůǁŚŝĐŚ
connects the parasite to the host cell cytoplasm (Beyer et al. 2000; Huang et al. 2004; Umemiya et 
al. 2005). ůĞĐƚƌŽŶŵŝĐƌŽƐĐŽƉǇƐƚƵĚŝĞƐŝĚĞŶƚŝĨŝĞĚĂŶ ‘ĞůĞĐƚƌŽŶĚĞŶƐĞďĂŶĚ ?ĂƚƚŚĞŝŶƚĞƌĨĂĐĞďĞƚǁĞĞŶ
the parasite and host membrane, with the appearance of a feeder organelle visible (Bonnin et al. 
2001). The feeder organelle has been hypothesised as a mechanism of myzocytosis engaged in by 
other gregarines, however no studies have shown transfer of host cytoplasm to the parasite. The 
ATP binding cassette protein CpABC-1 is localised to the host-parasite interface (Perkins et al. 1999; 
Zapata et al. 2002) and likely confers selective nutrient uptake and/or metabolite expulsion. Beyer 
and colleagues demonstrated replicative stages remain intracellular, but extracytoplasmic in rat 
ileal cells, but that the parasite can be found within the cytoplasm of intraepithelial macrophages 
in vivo (Beyer et al. 2000), indicating that the occupied niche may be tissue or cell type specific. The 
life cycle progresses through rounds of asexual merogeny followed by fertilisation of gamonts, 
development of zygotes and oocyst production. Scanning electron microscopy work in the HCT-8 
cell line has given a rough timeline of life cycle progression, with trophozoite development 
occurring after 24 hours of infection, type II merozoites appearing after 48 hours of infection and 
gametes being found after 96 hours (Borowski et al. 2010). 
While Cryptosporidium has long been considered an obligate intracellular pathogen, there is some 
evidence that suggests that these parasites show similar properties to gregarines in that they are 
capable of both replicating both within a host cell and extracellularly. The first researcher to 
observe this was (Hijjawi et al. 2004), who demonstrated through light microscopy that the entire 
life cycle of C. parvum could be completed in axenic culture. This was followed by electron 
microscopy studies of C. parvum in cell culture which demonstrated the presence of extracellular 
stages with similar cell structure to gregarines, such as large extracellular multinucleated stages, 
spores containing 8 sporozoites, motile trophozoites/gamont-like stages and of syzygy occurring (a 
pairing of two mature trophozoites, followed by wall formation around the cells, which develop 
into gametes and subsequent fertilisation and oocyst development) (Rosales et al. 2005). Aldeyarbi 
and Karanis have made similar findings in axenic culture, observing syzygy in both zoites early in 
culture (12 hours), gamont stages later in culture (120 hours) and syzgy of two parasites being 
enveloped by a double membrane at 168 hours (Aldeyarbi et al. 2016c). This study also highlighted 
the presence of protomerite and epimerite-like structures present on sporozoites. The 
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identification of sexual stages with transmission electron microscopy in axenic culture has also 
recently been reported (Aldeyarbi et al. 2016b). Parasites quickly entered the sexual stages of the 
life cycle, as early as half an hour after inoculation, which has not been observed previously in cell 
culture. Generated sexual stages also appeared to undergo syzygy, similarly to the observations 
made by (Borowski et al. 2010) and (Rosales et al. 2005) who observed microgamonts undergoing 
both syzygy and binary fission. The appearance of paired gamonts has also been observed, which 
could be undergoing binary fission (Rasmussen et al. 1993). Also, motile trophozoites and meronts 
have been observed by several groups (Hijjawi et al. 2004; Rosales et al. 2005; Borowski et al. 2010). 
In axenic culture, sporozoites generally have a banana shaped appearance, while merozoites have 
been described as bean shaped and rod shaped (Hijjawi et al. 2004; Rosales et al. 2005; Karanis et 
al. 2008). The work by (Karanis et al. 2008) claimed that the pre-treatment of bleach, used by many 
researchers to sterilise oocysts and prepare them for excystation, was damaging to internal 
sporozoites and caused death of the unusually shaped extracellular merozoites, which were 
observed to excyst directly from oocysts. The group attempted to maintain these stages in axenic 
culture but were unable to maintain them for more than 2 days. In an attempt to clarify the 
ƐŝŐŶŝĨŝĐĂŶĐĞŽĨƚŚĞƐĞ ‘ĞǆĐǇƐƚŝŶŐŵĞƌŽǌŽŝƚĞƐ ? and to reveal the nature of the observed extracellular 
 ‘ŵŽƚŝůĞƚƌŽƉŚŽǌŽŝƚĞƐ ?(Hijjawi et al. 2004; Aldeyarbi et al. 2016a) ĂŶĚ ‘ŐĂŵŽŶƚůŝŬĞƐƚĂŐĞƐ ?(Hijjawi 
et al. 2004; Rosales et al. 2005; Perez Cordón et al. 2007), (Petry et al. 2009) isolated sporozoites 
and kept them in the maintenance medium described by (Hijjawi et al. 2004) for 24 hours and three 
hours respectively, both groups observed that sporozoites became pear and oval shaped in the 
absence of host cells, and noted that some sporozoites appeared to have degraded (Petry et al. 
2009). In addition, these stages were not infectious to HCT-8 cells, while freshly excysted 
sporozoites (< 4 hours old) were. Although the switch to trophozoites would lead to a lack of 
invasive capability, (Matsubayashi et al. 2010) have observed similar morphology changes and have 
ƐŚŽǁŶ ƚŚĂƚ ƚŚĞ ĐŚĂŶŐĞ ĨƌŽŵ ƚƌĂĚŝƚŝŽŶĂů  ‘ďĂŶĂŶĂ ƐŚĂƉĞĚ ? ƚƌŽƉŚŽǌŽŝƚĞƐ ƚŽ  ‘ĐĂƐŚĞǁ ŶƵƚ ? ĂŶĚ
 ‘ƌŽƵŶĚĞĚ ?ƐƚĂŐĞƐǁĂƐĂĐĐŽŵƉĂŶŝĞĚďǇĂƌĞĚƵĐƚŝŽŶŝŶǀŝĂďŝůŝƚǇ ?ǁŝƚŚƚŚĞĨŝŶĂů ‘ƌŽƵŶĚ ?ĨŽƌŵƐƐŚŽǁŝŶŐ
only 49.2 % viability after three hours incubation.     
 In light of morphological and phylogenetic similarities, Cryptosporidium has been 
reclassified from a coccidian to a gregarine (Ryan et al. 2016). Other evidence to support this change 
includes the lack of an apicoplast (a remnant plastid present in many other apicomplexans, 
including Plasmodium and Toxoplasma), a similar morphology (Aldeyarbi et al. 2016a) and the 
ability to complete its life cycle in the absence of host cells (Hijjawi et al. 2004; Koh et al. 2013; Koh 
et al. 2014; Aldeyarbi et al. 2016b). Other phylogenetic evidence has also shown the relationship 
between Cryptosporidium and the gregarines. Sequence comparisons of the gregarines and 
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Cryptosporodium confirmed the view that the gregarines are an early emerging branch of the 
apicomplexans and that Cryptosporodium is a sister group of the gregarines (Carreno et al. 1999). 
The cell biology of Cryptosporidium infection has been widely documented using various 
microscopy techniques, however live cell imaging allowing progress to be tracked in real time is still 
lacking. In addition, the molecular basis of the life cycle changes has yet to be discerned. In the 
future, with improved genetic tools such as CRISPR/Cas (Vinayak et al. 2015), it may be possible to 
routinely transfect Cryptosporidium to identify crucial functional genes, their roles and possible 
vaccine targets.  
1.5 In vitro Culture  
The major barrier which inhibits a greater understanding of this organism is a lack of a reproducible 
culture method capable of supporting the parasite life cycle long term (Hijjawi 2010; Ryan et al. 
2015). The problems arise from the complex life cycle and the unclear mechanisms this parasite has 
for entering different stages. When selecting a suitable host cell culture, the options are generally 
limited to cancer derived cell lines for long term culture, due to the innate immortality of these cell 
lines, the availability of these cell lines from culture collections and their ease of use. The use of 
primary cell lines and stem cells can provide more accurate in vivo models of intestinal infection, 
and can provide higher yields of C. parvum stages (Castellanos-Gonzalez et al. 2013; Varughese et 
al. 2014; DeCicco RePass et al. 2017), but the short life span of these cells and finding sources of 
these can prove difficult. Cell lines are limited in their ability to support the parasites life cycle 
completely and to support continuous development, which tends to plateau after a week in culture, 
and often sooner (Current et al. 1983; Current et al. 1984; Flanigan et al. 1991). Prolonged 
development requires host cells which support the complete life cycle, lack a tendency to overgrow, 
and produce a high yield of both oocyst types to propagate new infections and to continue existing 
infective cycles. 
The first in vitro culture system of C. parvum utilised endoderm cells of the chorioallantoic 
membrane of chicken embryos and completed its life cycle between three and eight days (Current 
et al. 1983). Substantial developments have been made in cell culture since, utilising several cell 
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Table 2 - Summary of cell lines reported as supporting C. parvum replication. Where multiple cell 
lines are listed, subsequent data refers to those in bold.      




(Hubbard broiler and 
White Leghorn 





N/A 8 days Complete 
life cycle  
(Current et al. 
1983) 




AIDS patient  Minimal Essential Media with 
ĂƌůĞ ?Ɛ^ĂůƚƐ, 2 % FBS 
7 days Complete 
life cycle 
(Current et al. 
1984) 
HT29.74, Clone of 
colorectal cell line 
HT29 
AIDS patient RPMI-1640, 10 % FBS, 24 mM 
sodium bicarbonate, 1 mM 
sodium pyruvate, 20 mM 
HEPES (for undifferentiated 
cells), Leibovitz L-15 medium 
containing 5 mM galactose, 6 
mM pyruvate, 1 mM L-
glutamine, 20 mM HEPES, 
antibiotics, 10% dialyzed 
fetal calf serum (for 
differentiated cells) 
13 days, rapid loss 
of reinfection after 










RPMI-1640, 10 % inactivated 
FBS 






(Martinez et al. 
1992) 




infected calves  
Dulbecco's modified Eagle's 
medium and Ham's F12 
medium (1:1 ratio), 10 % FBS, 
10 mM HEPES, 5 µg bovine 
insulin, 2 % NaHCO3 (w/v) 
4 days Complete 
life cycle  




Infected calves Minimal Essential Media, 10 
% FBS 
5 days Complete 
life cycle  






RPMI-1640, 10 % Inactivated 
FBS 














N/A 5 days Complete 
life cycle 






(Villacorta et al. 
1996, Upton 
1994) 
Minimal Essential Media, 26 
mM  NaHCO3, 4 % FBS 
(Villacorta), RPMI-1640 with 
L-glutamine, 10 % FBS, 26 
mM NaHCO3, 15 mM HEPES 
(Upton) 
3 days  Complete 
life cycle  










Infected cows RPMI-1640 with L-glutamine, 
10 % FBS 







Clinical isolate Medium 199, Earles salts; 
essential amino acids, L-
glutamine, 0.075% w/v 
sodium bicarbonate, 10 % 
FBS 
5 days Not 
described 
(Dawson et al. 
2004) 
BS-C-1 (African green 
monkey kidney cells) 
Infected calves Minimal Essential Media, 2 
mM L-glutamine, 10 % FBS 
3 days  Complete 
life cycle 
(Qi Deng et al. 
1998) 
COLO-680N  Commercial 
source (infected 
cows) 
RPMI-1640 with L-glutamine, 
10 % FBS 
8 weeks Complete 
life cycle 
(Miller, Jossé, et 
al. 2017) 
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It has been found that the level of HCT-8 infection can be increased with medium supplementation 
(Upton et al. 1995). With a base medium of RPMI-1640, ascorbic acid, para-aminobenzoic acid, folic 
acid and sodium pantothenate had an enhancing effect on parasite growth, as did increasing FBS 
from 5 % to 10 % v/v in the medium. Additional sugar supplements (glucose, maltose, galactose 
and mannose) and insulin also had a positive effect. The final supplemented medium, consisting of 
RPMI 1640 with 10% fetal bovine serum, 15 mM HEPES, 50 mM glucose, and 35 mg of ascorbic acid, 
1.0 mg of folic acid, 4.0 mg of 4-aminobenzoic acid, 2.0 mg of calcium pantothenate, 0.1 U of insulin, 
100 U of penicillin G, 100 mg of streptomycin, and 0.25 mg of amphotericin B per ml (pH 7.4) 
supported a ten-fold increase in parasite development compared to base RPMI-1640 (Upton et al. 
1995). This medium is commonly employed when culturing C. parvum, although another medium 
formulation has been developed which can maintain HCT-8 cells and parasitism for 2 weeks (Perez 
Cordón et al. 2007). This medium formulation consists of RPMI-1640 medium with 10% heat 
inactivated FBS, pH 7.2 with CaCl2 and MgCl2 at 1 mM, and also requires the cells (HCT-8) have no 
medium renewal for a week prior to infection (Perez Cordón et al. 2007).   
 Another key process in C. parvum culture is the excystation protocol used to prepare 
oocysts for infection. Numerous laboratories use differing excystation protocols, with the number 
of excysted sporozoites vs the number of oocysts being used as a measure of viability. It has recently 
been established that the methods described by (Rasmussen et al. 1993) provides the highest rate 
of excsytation (Pecková et al. 2016). While long term culture in a single culture vessel is impossible 
with the HCT-8 cell line, Hijjawi reported the culture of C. parvum in HCT-8 cells for 25 days through 
sub-culturing (Hijjawi et al. 2001). This was attributed to maintaining the pH of the culture medium 
between 7.2 and 7.6 by changing the culture medium every 2-3 days. Numerous reports have 
described the decrease in life cycle stages after a week of culture (Current et al. 1984; Flanigan et 
al. 1991; Martinez et al. 1992; Rasmussen et al. 1993; Rosales et al. 1993; Upton, Tilley, Nesterenko, 
et al. 1994; Villacorta et al. 1996). The addition of fresh nutrients and maintaining physiological pH 
may be key to preserving the life cycle for prolonged periods of time. The success may also be 
attributed to HCT-8 monolayers up to 67 days old being capable of supporting infection (Sifuentes 
et al. 2007). More recently, C. parvum infection was maintained for 120 hours using primary human 
intestinal epithelial cells, which provided a significantly longer infection time compared to 48 hours 
using HCT-8 cells (Castellanos-Gonzalez et al. 2013). Primary cells provide advantages over cancer 
derived cell lines, such as retaining tissue markers and morphology and providing more accurate in 
vivo models (Varughese et al. 2014). The disadvantages are the considerable skill required to 
cultivate these cells, and the finite lifespan means there is need for a continued supply of these 
cells from animal or human tissues. Morphology of host cells has not been studied in great detail, 
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however some cell lines which support infection have been reported as having microvillus like 
extensions (Current et al. 1983; Upton et al. 1994; Flanigan et al. 1991). These extensions may play 
an important role in parasite development, as the observations that microvillus proteins localise to 
the parasite attachment site (Bonnin et al. 1999) and given the nature of encapsulation by the host 
cell (Chen et al. 2003; Borowski et al. 2010) host cell morphology may be worth investigating.  
As an obligate intracellular pathogen, there has been considerable interest in propagating the 
parasite in the absence of host cells. This method has considerable advantages compared to host 
cell culture, overcoming the issues of host cell overgrowth and the need to purify the parasite from 
host cell material. The first report of in vitro culture was by Hijjawi in 2004, who described the entire 
life cycle of C. parvum in host cell free culture (Hijjawi et al. 2004). Utilising a modified version of 
RPMI 1640 with supplements and coagulated calf serum (Hijjawi et al. 2004) observed stages from 
inoculated sporozoites through to sporulated oocysts, along with additional extracellular stages. 
Previously, novel extracellular stages had been purified from the guts of infected mice  (Hijjawi et 
al. 2002). Unfortunately, the results observed were not readily reproducible by other groups 
(Girouard et al. 2006; Woods et al. 2007). Woods and Upton observed that the figures reported as 
ďĞŝŶŐ ‘ĞǆƚƌĂĐĞůůƵůĂƌŐĂŵŽŶƚůŝŬĞƐƚĂŐĞƐ ?ǁĞƌĞŵŽƌĞůikely to be fungal contaminants (Woods et al. 
2007) given the similar morphology and the lack of antifungals in the culture medium (Hijjawi et al. 
2004). (Karanis et al. 2008) was capable of culturing the merozoite stages of the parasite, which 
were released directly from oocysts but could not be maintained in RPMI-1640. As discussed earlier, 
(Petry et al. 2009) and (Matsubayashi et al. 2010) have determined that ŽďƐĞƌǀĞĚ ‘ŵĞƌŽǌŽŝƚĞƐ ?ǁĞƌĞ
in fact aged sporozoites. A recent study using the described maintenance medium (Hijjawi et al. 
2004) to culture C. parvum and showed stages using scanning electron microscopy. Only stages 
from inoculated oocysts to type I merozoites were described, and there were no cases of either 
sexual stages or the previously described  ‘ĞǆƚƌĂĐĞůůƵůĂƌŐĂŵŽŶƚůŝŬĞƐƚĂŐĞƐ ?(Hijjawi et al. 2004) in 
culture (Yang et al. 2015). Recently, Aldeyarbi and Karanis have had success in developing the 
complete life cycle of C. parvum in the absence of host cells using cell free maintenance medium 
ǆƉƌĞƐƐ&ŝǀĞ ?serum free medium (Aldeyarbi et al. 2016b; Aldeyarbi et al. 2016c; Aldeyarbi et al. 
2016a). The completion of the life cycle in serum free media is interesting, as the maintenance 
medium described by (Hijjawi et al. 2004) required coagulated newborn calf serum to form the 
biphasic medium, and that increasing the FBS concentration in HCT-8 medium caused a doubling of 
parasites visible on host cells (Upton et al. 1995). Woods and Upton found numerous serum free 
media alternatives which functioned as well as RPMI-1640 + 2 % serum, enumeration of parasites 
using ǆƉƌĞƐƐ &ŝǀĞ ? serum free medium would reveal the comparative ability to develop the 
parasite. Unfortunately, there is still a need for long term and productive culture methods, 
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especially methods which maintain life cycle stages in culture. With improvements in cell culture 
and with optimal media design, it may be possible in the future to harvest C. parvum in axenic 
culture.  
The need for long term and high yield production of oocysts has led to an interest in 3D culturing 
systems and organoid models. These systems allow for higher cell densities and subsequent 
parasite yields, along with allowing long term parasite propagation. The 3D culture environment 
can also provide a more accurate model of in vivo infection. Early efforts to develop 3D culture used 
HCT-8 cells in a low shear microgravity environment, incubated with porcine small intestinal grafts 
to promote differentiation into cuboidal epithelia and brush border formation (Alcantara Warren 
et al. 2008). This method allowed the intestinal epithelium to increase parasite numbers for 48 
hours, however the infection reduced after this time, accompanied by a reduction in host cell 
attachment (Alcantara Warren et al. 2008). This provides a proof of concept, that bioreactor 
systems can be used to produce C. parvum parasites, and with the additional medium supplements 
described by Upton (Upton et al. 1995) or Cordon (Perez Cordón et al. 2007) this system may be 
adapted as a productive culture method. Following this, the culture of C. parvum was recently 
reported using a hollow fiber bioreactor system and maintained for over 6 months (Morada et al. 
2016). This system produced 1 x 108 oocysts per day per mL of culture compared with a reported 1 
x 106 oocysts produced in traditional 2D culture vessels. Another recent report described the 
culture of C. parvum in a model intestinal system developed using a silk fibre scaffold, which 
supported infection for two weeks (DeCicco RePass et al. 2017). While this method provides a good 
model of in vivo cryptosporidiosis, the use of multiple cell lines including intestinal myofibroblasts 
and the need for specialist equipment is a large cost barrier for many labs. For long term 
cryptosporidium culture, the adoption of 3D culture technology by several labs will require a low 
cost methodology and simple protocol which allows routine harvesting of large numbers of oocysts.  
Cryptosporidium culture has seen large improvements over the last 30 years, however continuous 
routine propagation of C. parvum in vitro still eludes researchers. Assessment of cell lines which can 
withstand the parasite burden, avoid overgrowth and produce a high yield of oocysts is key to 
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1.6 Project Aims  
Given the urgent need for enhanced culture methods, this project aimed to develop the in vitro 
culture of C. parvum. Many researchers use HCT-8 cells when studying C. parvum, but this cell line 
has limited ability to produce oocysts for more than three days. Given the recent success in our lab 
cultivating the parasite for up to a week using the oesophageal adenocarcinoma derived cell line, 
COLO-680N, this length of time was set as the benchmark. A total of 17 cancer cell lines were tested 
for their ability to support the C. parvum life cycle. Given the undifferentiated nature of many 
cancer cell lines, the cell lines were picked at random for this project. These included a 
neuroblastoma, a melanoma, several breast cancers, colorectal cancers, lung cancers and ovarian 
cancers, as many of these cancer types have not been tried previously or have had only a single cell 
line of that type tested.   
To track the progression of the life cycle, fluorescent microscopy was used, utilising a nuclear stain 
(DAPI), a mitochondrial marker (Mitotracker Red CMXRos ? ) and antibodies specific for C. parvum 
(Sporo-Glo ? and Crypt-a-Glo ?). Cell lines were incubated for a week before staining and were then 
compared for their ability to propagate infection. In addition, the presence of parasite DNA in the 
media of infected cultures was tested using PCR with primers against random DNA fragments 
(RAPD) used for detecting C. parvum in environmental water supplies. Cell lines showing complete 
development were used to establish sub-infections of cell monolayer using in vitro produced 
oocysts with weekly passages, and the oocysts enumerated after three weeks. In addition, to 
address the limited long term culture methods currently available, a bioreactor system was 
established using COLO-680N in an attempt to culture the parasite long term i.e. over a month. 
Production was tracked by enumerating oocysts being produced and with fluorescent microscopy. 
Establishing an effective bioreactor using COLO-680N will be an important proof of concept, and 
will allow future work to try other cell lines and media optimisations, which if previous reports are 
to be believed, will conceivably give a 2 to 10 fold increase in parasite production. This will allow a 
wider range of labs to study C. parvum and will enable continuous oocyst production unrestricted 
by seasonal harvests. Harvesting and purifying from such a system will be far less labour intensive 








2.1 Cell Culture  
Cell lines were revived from cryopreservation in liquid nitrogen or were subcultured from existing 
cultures. Cells were frozen in cryopreservation media (standard growth medium (Table 3) with 5 % 
DMSO). All reagents were warmed to 37 °C in a water bath prior to use. Foetal bovine serum (FBS) 
(Sigma-Aldrich, Lot No. BCBR0289V) was thawed completely before being heat-shocked at 56 °C for 
30 minutes prior to use. All media (except RPMI-1640) was purchased from Thermo Fisher Scientific 
(IMDM Lot No. 1838127, MEM Lot No.1816890), RPMI-1640 was purchased from Sigma-Aldrich 
(Lot No. RNBF8560). All cell lines had antibiotics added to a final concentration of 100 U/mL 
penicillin and 100 µg/mL streptomycin per mL (Thermo Fisher Scientific). In the bioreactor system, 
0.25 ʅŐ ?ŵ>ĂŵƉŚŽƚĞƌŝĐŝŶ ?^ŝŐŵĂ-Aldrich) was included in the culture medium. 
2.2 Cell Line Revival  
Cell lines were kept on dry ice until revival. Prior to revival, 4 mL of growth medium (Table 3) were 
placed in a T25 tissue culture flask (Sarstedt or Jet BioFil®) and warmed in a tissue culture incubator 
at 37 °C, 5 % CO2 for at least 15 minutes. Cryovials containing cells in cryopreservation media were 
warmed in a 37 °C water bath while gently shaking for no more than 2 minutes. Cells were then 
transferred to a 15 mL falcon tube containing 3 - 4 mL standard medium (final volume 5 mL) and 
pelleted at 300 x g for 3 minutes. The supernatant was then discarded and the cells were 
resuspended in 1 mL of medium and transferred to the warmed T25 flask. After 24 hours the growth 
medium was carefully aspirated from the T25 flask, and replaced with warm fresh medium. Once 
revived, cells were passaged twice to ensure complete recovery from cryopreservation (see section 
2.3).  
2.3 Routine Subculture  
Cells were inspected daily for contamination and to check confluency. When cells reached 80-90 % 
confluency, medium would be aspirated from the culture vessel. The cell monolayer was then 
rinsed with phosphate buffered saline (PBS - Dulbecco A, OXOID) which was then aspirated off.   
0.25 % trypsin EDTA solution (Thermo Fisher Scientific) was added to the flask; 1 mL to T25s, 3 mL 
to T75s and 5 mL to T175s. Flasks were then placed in an incubator (37 °C, 5 % CO2) for 3 - 5 mins 
to allow cells to detach. Detachment was observed by eye and light microscopy. Warm growth 
medium was added to the flask (4 mL for T25s, 7 mL for T75s and 10 mL for T175s) to deactivate 
trypsin. Solution was then transferred to a 15 mL falcon tube and pelleted at 300 x g for 3 mins. 
Supernatant was then discarded and the pellet resuspended in the same volume of warm medium 
as the previous flask (T25  W 5 mL, T75  W 15 mL, T175  W 30 mL). Warm medium was then added to a 
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clean culture vessel. Cell suspension was then added to the new vessel. For routine passage, cells 
were passaged at a split ratio (cell suspension: medium) of between 1:3 and 1:10. Fast growing cell 
lines (HCT-8, RKO, SW620, UFK-NB3, RKO, EFO-21 and EFO-27) were split at a lower density of 1:15 
to 1:20. Cell lines were maintained at 37 °C and 5 % CO2 in T25 flasks (Sarstedt or Jet Biofil®) in the 
media shown in Table 3.  
Table 3 - Growth media used for cell lines 
 
2.4 Cryptosporidium parvum excystation 
C. parvum oocysts (IOWA isolate) were purchased from Bunch Grass Farm, Deary, Idaho, and stored 
at 4 °C. For infection of the monolayer, an MOI of 2 was used (2 host cells per oocyst, equating to 
2 sporozoites per host cell). Oocysts were pelleted at 5,000 x g for 8 minutes, then the supernatant 
was discarded. Oocysts were resuspended in excystation solution (0.01% trypsin (final 
concentration) in 0.5% sodium hypochlorite) for 4 hours at 37 °C. After this time, sporozoites were 
pelleted at 2,000 x g for 8 minutes then resuspended in PBS. This step was repeated twice to wash 
sporozoites, before the pellet was resuspended in PBS again and used to infect cells (see section 
2.5). 
2.5 Cryptosporidium parvum Infection of 24 well Plates 
Cells were detached from flasks using 0.25 % trypsin EDTA (Thermo Fisher Scientific) incubating at 
37 °C for 5 minutes. Trypsin was inactivated with the respective media (Table 3) and cells were 
pelleted at 300 x g for 3 minutes. Cells were resuspended in medium and 10 ʅL was counted using 
a Bright->ŝŶĞ ? ŚĂĞŵŽcytometer (Sigma-Aldrich) and viability measured using trypan blue 
(InVitrogen ? )exclusion (5 µL of 0.4% trypan blue in 45 µL cell suspension). Sterilised cover slips 
Cell Line Base Medium Foetal Bovine Serum 
BT-474 IMDM  10 % 
CAMA-1 IMDM 10 % 
COLO-320 RPMI-1640 10 % 
COLO-680N RPMI-1640 10 % 
EFM-19 IMDM 10 % 
EFO-21 RPMI-1640 20 % 
EFO-27 RPMI-1640 20 % 
H2228 RPMI-1640 10 % 
HCC4006 RPMI-1640 10 % 
HCC827 RPMI-1640 10 % 
HCT-8 RPMI-1640 10 % 
IGR-39 IMDM 10 % 
LS-174T MEM 10 % 
MDA-MB-468 IMDM 10 % 
UKF-NB-3 IMDM 10 % 
RKO MEM 10 % 
SW48 IMDM 10 % 
SW480 IMDM 10 % 
SW620 IMDM 10 % 
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were placed into 8 wells of a 24 well plate, with cell lines seeded at 1.4 x 105 cells per well. Cells 
were allowed to attach overnight. Cell lines which exhibited faster growth such as UKF-NB-3 were 
seeded at lower density to account for growth, with a density of ~70% upon infection observed by 
light microscopy. 7 x 104 oocysts prepared as described in section 2.4 were then added to 4 of the 
wells, while control wells had the equivalent volume of PBS added. Monolayers were incubated at 
37 °C and 5 % CO2 overnight to allow sporozoites to infect cells. After 16 hours the medium was 
discarded and 1 mL fresh medium was added to each well. Plates were incubated at 37 °C and 5 % 
CO2 for a week to allow the infection to progress. Wells were inspected daily for contamination and 
contaminated plates were discarded.  
2.6 Cryptosporidium parvum infection of T25 Flasks 
Four T-25 flasks were detached and counted as described in section 2.5 and seeded at a cell density 
of 5.6 x 105 cells per flask. Three aliquots of 2.8 x 105 oocysts were excysted as described in C. 
parvum excystation and were inoculated into the flask, with one flask being inoculated with PBS to 
act as a control, and were left overnight. The medium was then aspirated off and replaced with 5 
mL fresh growth medium.  
2.7 T25 Cryptosporidium parvum Passage  
Once a week, fresh T-25 flasks were seeded with 5.6 x 105 cells as described in section 2.6 and 
allowed to attach overnight. The following day, medium would be aspirated from an infected T-25 
flask, filtered through a 40 µm cell strainer and pelleted at 5,000 x g for 8 mins. The supernatant 
was discarded and the pellet resuspended in fresh growth medium. The freshly seeded T-25 flask 
had the medium aspirated and replaced with the oocyst suspension.  
2.8 Fluorescent Microscopy of Infected Monolayers 
After the infection the medium was extracted (see section 2.9). Mitotracker ? Red CMXRos 
(Molecular Probes, InVitrogen ? ) ?was used at a 250 nM concentration in serum free base medium 
for the respective cell line (Table 3). 0.5 mL of this was added to each well, with plates wrapped in 
tin-foil and incubated at 37 °C and 5 % CO2 for 15 - 45 minutes. Mitotracker ? solution was discarded 
and cells were fixed in 4 % paraformaldehyde for 10 minutes. Cells were permeabilised with 0.5 % 
Triton X-100 in PBS for 5 minutes on ice. Cells were washed twice in 0.5 mL PBS. Cells were blocked 
for half an hour in 3 % bovine serum albumin (BSA). BSA solution was discarded and a drop of 1 x 
Sporo-Glo ? antibody solution (Waterborne Inc.) was added to each infected well, and incubated 
for 1 hour at room temperature. Cells were then washed twice in 3 % BSA in PBS and were allowed 
to dry. Slides were prepared by coating with a 1:10 dilution of poly-L-lysine and left to dry at 56 °C 
for an hour. A drop of Fluoroshield ? with DAPI (Sigma-Aldrich) was added to the slides, and cover 
A. J. Bones 2017 
26 
 
slips were extracted from each well and placed with cells face down onto the slide. Cover slips were 
sealed with nail varnish and slides were stored at 4 °C in the dark. Slides were visualised on an 
Olympus IX81 and images captured using an Andor Zyla 4.2 plus sCMOS camera. 
2.9 Oocyst Harvesting 
After infection, medium was carefully aspirated from wells, placed into 1.5 mL microfuge tubes and 
pelleted at 300 x g for 3 mins. The supernatant was then transferred to a fresh tube and pelleted at 
5,000 x g for 8 mins, the supernatant was discarded and 100 ʅ>W^ǁĂƐĂĚĚĞĚ. This process was 
repeated twice, before the pellet was resuspended in 50 ʅ> PBS containing 100 U/mL penicillin and 
100 µg/mL streptomycin. Samples were stored at 4 °C.  
2.10 Oocyst Fluorescent Microscopy 
12 well microscope slides were soaked in poly-L-lysine for 10 minutes then dried at 56 °C for 1 hour. 
10 ʅ> of oocyst suspension was then added to each well and allowed to dry in a 37 °C dry incubator. 
Samples were then fixed with ice cold methanol, which was allowed to dry. Once dry, samples were 
then blocked with 20 ʅ>ŽĨ 3 % BSA in PBS for half an hour at room temperature. Slides were rinsed 
once in PBS before being incubated with one drop (~ 45 ʅ> )1 x Crypt-a-'ůŽ ?antibody solution 
(Waterborne Inc.) at 37 °C for 25 minutes or at room temperature for 1 hour, in the dark. Antibody 
was rinsed by adding 20 µL PBS to each well for 1 minute, then tilted to allow the PBS to drain off. 
This process was performed twice before being allowed to dry completely at room temperature 
while being kept in the dark. Once completely dry, one drop (~ 45 ʅL) of FluoroShield ? with DAPI 
(Sigma-Aldrich) was added to each well and left for 3 minutes. A coverslip was then added to each 
slide and slides were sealed with nail varnish (Boots). Slides were stored at 4 °C in the dark. Slides 
were visualised on an Olympus IX81 at 600x and 1000x magnification, and images captured using 
an Andor Zyla 4.2 plus sCMOS camera. 
2.11 Oocyst Enumeration  
Oocysts were quantified using a Bright->ŝŶĞ ? ,ĞŵĂĐǇƚŽŵĞƚĞƌ (Sigma-Aldrich). 45 ʅ> ŽĨ ŽŽĐǇƐƚ
ƐƵƐƉĞŶƐŝŽŶǁĂƐŵŝǆĞĚǁŝƚŚ  ?ʅ>  ? ? ?A?ƚrypan blue (InVitrogen ? ) ?  ? ?ʅ>ǁĂƐ ƚŚĞŶ added to the 
haemocytometer grid. Each sample had the four corner chambers counted and an average taken, 
40 x objective with a 10 x eyepiece, 400 x total magnification. 
2.12 Glucose Consumption  
Cells were detached from culture flasks using 0.25 % trypsin EDTA (Thermo Fisher Scientific) and 
resuspended in culture medium. 45 µL of cell suspension was mixed with 5 µL 0.4 % trypan blue 
(InVitrogen ?) and counted using a Bright->ŝŶĞ ? ŚĂĞŵŽcytometer (Sigma-Aldrich). Cells were 
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seeded into a 24 well plate (Jet BioFil®) at a density of 2 x 105 cells per well and left overnight. 
Sporozoites were then prepared as described in excystation. Parasites were inoculated at an MOI 
of 2 and allowed to invade overnight. Uninfected control wells had 5 ʅ>ŽĨW^ĂĚĚĞĚ ? Medium was 
added and replaced with 1 mL fresh medium per well. Samples were taken after 6 hours, 24 hours, 
48 hours, 72 hours, 96 hours, 120 hours, 144 hours and 168 hours after the medium change. 45 ʅ>
of medium was taken from each well and tested using the Accu-ŚĞŬ ?ǀŝǀĂglucose testing system 
(Roche Applied Science) 
2.13 Bioreactor System  
The miniPERM® SM bioreactor was purchased from Sarstedt AG & Co., Germany. Confluent T-175 
flasks containing COLO-680N cells were detached and pelleted as described in section 2.3. Cell 
pellets were then resuspended and pooled in 50 mL of culture medium containing 36.8 x 106 COLO-
680N cells. The cell suspension was drawn into a 50 mL syringe and inoculated into the production 
module through the sample port. 400 mL of culture medium warmed to 37 °C was added to the 
nutrient module. The bioreactor was then placed on a roller (SLS Lab Basics) in an incubator and 
maintained at 37 °C, 5 % CO2 at a speed of 10 rpm. After 24 hours, oocysts were prepared as 
described in section at a MOI of 2, with sporozoites being resuspended in 1 mL of PBS. 1 mL of 
culture medium was then removed from the production module and the sporozoite suspension was 
inoculated into the production module before being returned to an incubator. Once a week, the 
nutrient module would be emptied of medium and replaced with fresh medium warmed to 37 °C. 
2.14 Bioreactor Harvesting 
Once a month 25 mL of production module medium was removed and replaced with fresh medium. 
dŚĞĐĞůůƐƵƐƉĞŶƐŝŽŶǁĂƐƚŚĞŶĨŝůƚĞƌĞĚƚŚƌŽƵŐŚĂ ? ?ʅŵnylon Corning® cell strainer (Sigma-Aldrich) 
to remove large clumps of cells, transferred to a 15 mL falcon tube and spun at 5,000 x g for 8 
minutes. The pellet was washed twice in PBS then resuspended in PBS containing 100U/mL 
penicillin 100 µg/mL streptomycin. Samples were stored at 4 °C. 
2.15 Bioreactor Produced Oocyst Infection 
Harvested samples from the bioreactor were kept at 4 °C for at least a week. A 70 % confluent 
monolayer was seeded as described in Cryptosporidium parvum infection. Harvested samples had 
oocysts counted as described in section 2.11. 7x 104 oocysts were treated as described in section 
2.4, followed by inoculation onto the monolayer as described in section 2.5, followed by overnight 
incubation and medium change. Infections of COLO-680N cells were allowed to incubate for a week, 
while HCT-8 infection was incubated for three days.  
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2.16 Cell Line DNA Extraction 
DNA from pellets of trypsinised cell lines were isolated using the QIAamp® DNA mini kit following 
ƚŚĞŵĂŶƵĨĂĐƚƵƌĞƌ ?Ɛ ŝŶƐƚƌƵĐƚŝŽŶƐ, before being eluted in DEPC treated water (Ambion). DNA was 
then quantified using a NanoDrop ? 1000 spectrophotometer (Thermo Fisher Scientific). 
2.17 Oocyst DNA Extraction 
For positive control DNA, genomic C. parvum DNA was extracted from commercially supplied 
oocysts ƵƐŝŶŐƚŚĞY/ĂŵƉ ?EŵŝŶŝŬŝƚĨŽůůŽǁŝŶŐƚŚĞŵĂŶƵĨĂĐƚƵƌĞƌ ?ƐŝŶƐƚƌƵĐƚŝŽŶƐ ?^ĂŵƉůĞƐǁĞƌĞ
eluted in DEPC treated water (Ambion) and stored at - 20 °C.  
2.18 Oocyst Preparation for PCR 
Oocysts were isolated as described in oocyst harvesting. Oocyst suspension was diluted 1:10 in 
DEPC treated water (Ambion) and boiled at 100 °C for 20 mins. 5 ʅ>ŽĨƚŚŝƐǁĂƐƵƐĞĚĚŝƌĞĐƚůǇĂƐĂ
PCR template.  
2.19 PCR Reactions 
Two PCR reactions were performed using the SB012 primer set (Wu et al. 2000) to test for C. parvum 
DNA and Hs18S (Miller et al. 2017) as a positive control when assessing specificity of the SB012 
primers. SB012 forward primer sequence:  ? ?-ATAAACAAGCAGGAAAAAAGGT- ? ? ? ƌĞǀĞƌse primer 
ƐĞƋƵĞŶĐĞ  ? ?- CGCACAAGTTACAAGGATTATT- ? ? ? ,Ɛ ? ?^ ĨŽƌǁĂƌĚ ƉƌŝŵĞƌ ƐĞƋƵĞŶĐĞ P  ? ?-
GGCGCCCCCTCGATGCTCTTAG- ? ? ?ƌĞǀĞƌƐĞƉƌŝŵĞƌƐĞƋƵĞŶĐĞ ? ?-TTTCAGCTTTGCAACCATACTCC- ? ? ? 
Reactions were run with a 25 ʅ>ǀŽůƵŵĞƉĞƌƌĞĂĐƚŝŽŶ ?ZĞĂĐƚŝŽŶŵŝǆƚƵƌĞ(per tube) consisted of 2.5 
ʅL PCR buffer with 20 mM MgCl2, 0.5 ʅL 10 mM dNTP mix (Roche Applied Science), 0.2 ʅL FastStart 
Taq Polymerase (5U/ʅL) (Roche Applied Science) and 10 nM of the appropriate primers. Remaining 
volume was made up using DEPC treated water to 25 ʅL. SB012 reactions had an initial denaturation 
of 94 °C for 6 mins, followed by 40 cycles of 94 °C for 30 seconds, annealing temperature of 51 °C 
for 30 seconds and an extension temperature of 72 °C for one minute. A final extension of 72 °C for 
10 minutes was used. For the Hs18S sequence reaction an initial denaturation of 95 °C for 5 mins 
was used, followed by 36 cycles of 95 °C denaturation for 35 seconds, 52 °C extension for 20 seconds 
and an elongation of 72 °C for 20 seconds, with a final elongation of 72 °C for 10 minutes. The Hs18S 
reaction used 100 ng of extracted cell line DNA as a template.  
2.20 Gel Analysis 
2 % agarose gels were cast containing 7 ʅL ethidium bromide per 100 mL gel. 25 ʅL samples were 
mixed with 5 ʅL loading buffer (40% glycerol, 1mM EDTA, 0.001% bromophenol blue, 0.25% xylene 
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cyanol FF). 15 ʅL of sample was loaded per well. Images of gels were captured using a G:BOX gel 


























3.1 Fluorescent Microscopy of Infected Cells 
Host cells were incubated with pre-treated C. parvum oocysts at a ratio of 2 host cells per oocyst, 
with unexcysted oocysts removed after 16 hours incubation. After a week incubation, slides were 
prepared of infected monolayers and C. parvum stages visualised with fluorescent microscopy. 17 
cell lines were tested, 16 of which have not been described previously and one (LS 174T) being 
tested previously for only three days. Three fluorescent markers were used ? DŝƚŽƚƌĂĐŬĞƌ ? ZĞĚ
CMXRos stained mitochondria and indicates live cells and shows the area of host cell cytoplasm, 
4',6-diamidino-2-phenylindole (DAPI) stained nuclei of C. parvum and host cells, and Sporo-'ůŽ ?
monoclonal antibody conjugated with fluorescein isothiocyanate (FITC) stained intracellular 
dividing stages of C. parvum (trophozoites, meronts I & II, gamonts and zygotes). 10 cell lines were 
found to contain stages of C. parvum, four of these showed evidence of the complete life cycle and 
were used to establish sub-infections (see section 3.4).  
IGR-39 
Melanoma cell line, active after one week, showing no visible intracellular stages of C. parvum.  
UKF-NB-3 
Neuroblastoma with a fast growth rate, active after one week but no intracellular growth of C. 
parvum was observed.  
EFO-21 
An ovarian cystadenocarcinoma. While cells appeared attached and showed mitochondrial activity 
after the week incubation, there were no visible instances of intracellular C. parvum infection. 
EFO-27  
An ovarian mucinous adenocarcinoma. Cells showed mitochondrial activity and were attached, but 
no intracellular C. parvum stages were observed.  
LS 174T 
LS 174T exhibits similar morphology to the COLO-680N cell line, forming colonies with large circular 
gaps between colonies. While cells appeared alive after the week, no C. parvum infection was 
observable after the week incubation.  
 




A non-small cell lung adenocarcinoma, and appeared healthy after the week incubation. 
Mitotracker ? and DAPI signals were present, but no evidence of Sporo-'ůŽ ? ůĂďĞůůĞĚ ƉĂƌĂƐŝƚĞƐ
could be seen. 
SW48 
A Dukes' type C, grade IV, colorectal adenocarcinoma. Cells appeared active at the end of the week 
but no intracellular stages of C. parvum were observed.  
BT-474 
A breast/duct cancer, exhibiting fairly slow growth. BT-474 showed evidence of trophozoite and 
merozoite replication, however no intracellular sexual stages were observed. Parasites developed 
in the cytoplasm (Fig. 2); active mitochondria can be observed in all figures indicating cells are alive. 
Intracellular stages appeared to be mostly limited to trophozoites (Fig. 2). Compared to other cell 
lines, this cell line showed a moderate level of infection after a week in culture. Uninfected control 



















Figure 2 - Infected BT-474 cell line. Sporo-Glo ?ĨŝůƚĞƌ (C) shows six regions labelled (white 
arrows). Mitotracker ? staining (B) shows some of these regions have signal in the Sporo-Glo ?
labelled regions (white arrows). DAPI stain (A) shows distinct nuclei in regions labelled with 
Sporo-Glo ? (white arrows). Merged image (E) shows all channels, DIC compares with light 
alone (D), with outlines of parasite stages partly visible (black arrows). Stages appear limited 
to asexual phase of life cycle, with trophozoites and meronts I present.   
Figure 3 - Uninfected BT-474 culture. Cells have grown as a monolayer (C). Mitotracker ? 
shows active cells (A), but no non-specific Sporo-Glo ? binding is observed (B). 




CAMA-1 is a breast/duct carcinoma. This cell line had a low level of infection throughout the 
observed slides, with an intracellular stage and two potential oocysts present in the observed fields 
(Fig. 4). Observed in Fig. 4 are two instances of four tightly clustered (within 5 microns) nuclei each 
measuring approximately half a micron in diameter. These nuclei likely belong to oocysts or type II 
merozoites within type II meronts, but given the lack of Sporo-'ůŽ ?ƐŝŐŶĂůƚŚĞƐĞĂƌĞŵŽƌĞůŝŬĞůǇƚŽ



















Figure 4 - Three parasite stages in CAMA-1 cells. Sporo-'ůŽ ?ƐƚĂŝŶŝŶŐ ? )ƐŚŽǁƐĂƐŝŶŐůĞ
intracellular (Int) stage. DAPI staining (A) reveals two stages with multiple small nuclei (Oo) 
with the Sporo-'ůŽ ?ůĂďĞůůĞĚƌĞŐŝon having a clouded appearance, possibly indicating a 
gamont or zygote stage. These regions show two rounded bodies under DIC (D, black arrows) 
and occupy areas devoid of mitochondria (B, white arrows). 





A breast carcinoma, with a tendency to form colonies appearing as clumps rather than forming a 
continuous monolayer. This cell line had a high level of C. parvum infection, as seen with the Sporo-
'ůŽ ?ůĂďĞůůŝŶŐ ?KŶĞĨĞĂƚƵƌĞŝƐƚŚĞƉƌĞƐĞŶĐĞŽĨďƌŝŐŚƚŵŝƚŽĐŚŽŶĚƌŝĂůĂĐƚŝǀŝƚǇĂƌŽƵŶĚƚŚĞƉĂƌĂƐŝƚĞƐ
(Figs. 6 & 7). Three parasites can be seen within a single host cell (Fig. 6), which may be due to 
invasion by multiple merozoites, or as a result of binary fission. In this field an extremely bright 
Sporo-'ůŽ ?ůĂďĞůůĞĚƌĞŐŝŽŶŝƐƉƌĞƐĞŶƚ ?ǁŚŝĐŚĂƉƉĞĂƌƐƚŽďĞĞǆĐǇƐƚŝŶŐĨƌŽŵƚŚĞƌŽƵŶĚĞĚŵĞƌŽŶƚƐ
(Fig. 6). Alternatively, this could be a merozoite which had just invaded the host cell prior to 
developing into a trophozoite. A faintly Sporo-'ůŽ ?ůĂďĞůůĞĚĂƌĞĂŝƐĂůƐŽƉƌĞƐĞŶƚ ?ǁŚŝĐŚŚĂƐĂƐŝŶŐůĞ
ŶƵĐůĞƵƐŵĞĂƐƵƌŝŶŐ  ?ʅŵĂĐƌŽƐƐ ? ŝŶĚŝĐĂƚŝŶŐĂ ƚƌŽƉŚŽǌŽŝƚĞƐƚĂge. All observed stages can be seen 
closely associating with the host nucleus (Figs. 6 & 7). In the second image, a mixture of sexual and 
asexual stages can be seen (Fig. 7), showing this cell line can support the complete life cycle. 
Uninfected cells are shown in Fig. 8.  
 
Figure 5 - Uninfected CAMA-1 cells. Mitotracker ? shows some activity (A) and cells appear 
nearly confluent (C), but no non-specific Sporo-Glo ? binding is observed (B). 














Figure 6 - Multiple parasites in EFM-19 cells. Sporo-'ůŽ ?ƐƚĂŝŶ ? )ƐŚŽǁƐƚǁŽƌŽƵŶĚĞĚ
meronts (Mer), a bright comma shaped merozoite (Zo) and a faintly labelled trophozoite 
 ?dƌŽƉ ) ?DŝƚŽƚƌĂĐŬĞƌ ?ƐƚĂŝŶŝŶŐƐŚŽǁƐĂƌeduced signal in these two rounded areas but a 
bright signal in the comma shaped region (B). DAPI stain (A) shows two distinct nuclei in the 
left meront and four in the top meront. A fainter Sporo-'ůŽ ?ůĂďĞůůĞĚƌĞŐŝŽŶ ? )ŝƐǀŝƐŝďůĞĂƚ
the bottom right (small arrow), with a discrete nucleus present in the DAPI field (A). Merged 
channels (E) show overlap of Sporo-'ůŽ ?ĂƌĞĂ ?ǁŝƚŚW/ƐŝŐŶĂůǁŝƚŚŝŶƚŚĞƐĞĂƌĞĂƐ ?/
shows multiple bodies visible correlating to the Sporo-'ůŽ ?ůĂďĞůůĞĚƌĞŐŝŽŶƐ ? ) ? 











Figure 8 - Uninfected EFM-19 cells. Mitotracker ? stain (A) shows active cells, but no non-
specific Sporo-Glo ? binding is observed (B). Cells have grown to confluency (C). 
Figure 7 ʹ Multiple C. parvum stages visible within EFM-19 cell culture. Sporo-'ůŽ ?ƐŝŐŶĂů ? )
shows five distinct labelled bodies; meront (Me), microgamonts (Mi), macrogamont (Ma) and 
ǌǇŐŽƚĞ ?Ǉ ) ? ) ?DŝƚŽƚƌĂĐŬĞƌ ?ƐŝŐŶĂů ? )ŽǀĞƌůĂƉƐƐŽŵĞŽĨƚŚĞ^ƉŽƌŽ-GlŽ ?ůĂďĞůůĞĚƌĞŐŝŽŶƐ ?DĂ ?
Zy). DAPI stain (A) shows distinct staining regions separate from the host cells and small nuclei 
in the parasite (Me, Mi stages). DIC (D) shows individual parasites are distinguishable. 
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MDA MB 468 
MDA MB 468 is a breast cancer adenocarcinoma derived from a metastatic site. This cell line 
supported the complete life cycle of C. parvum. Analysis of the host cell monolayer showed 
numerous stages stained with Sporo-'ůŽ ? ? including sexual stages (Fig. 9). The infectious stages 
were numerous in the culture, however also present were clouded regions containing small 









Figure 9 - Parasite stages in MDA-MB-468 cells. Sporo-'ůŽ ?ůĂďĞůůŝŶŐ ? )ŝŶƚŚŝƐĐĞůůůŝŶĞ
appears lĞƐƐĚŝƐƚŝŶĐƚ ?ǁŝƚŚŵŽƌĞ ‘ĐůŽƵĚǇ ?ĂƉƉĞĂƌĂŶĐĞ ?ĂŶĚĂƉƉĞĂƌůĂƌŐĞƌƚŚĂŶƌĞŐŝŽŶƐŽďƐĞƌǀĞĚ
in other cell lines. These also appear to contain multiple rounded bodies, which are visible 
ǁŝƚŚDŝƚŽdƌĂĐŬĞƌ ? ? ) ?W/ƐƚĂŝŶ ? )ƐŚŽǁƐĚŝƐĐƌĞƚĞŶƵĐůĞŝĂƚƐŽŵĞŽĨƚŚĞ^ƉŽro-Glo ? 
labelled regions, but not in the larger clouded ones. White arrows show stages more similar to 
those seen in other cell lines; trophozoites (Trop), microgamonts (Mi), microgametes (Mi*), 
and an oocyst which appears to be excysting (Oo).  
 





RKO cells are derived from a colon carcinoma and show poor differentiation. Cells showed a high 
level of proliferation, and as such after a week a large proportion of cells had detached leaving a 
low confluency slide. In addition, observed intracellular stages were few in number. These stages 
seem to be limited to trophozoites, with seemingly no DAPI staining of these areas (Fig. 11). The 
DŝƚŽƚƌĂĐŬĞƌ ?ƐŝŐŶĂůŽŶƚŚĞƐĞĐĞůůůŝŶĞƐǁĂƐĞǆƚƌĞŵĞůǇǁĞĂŬ ?ŝŶĚŝĐĂƚŝŶŐĚĞĂƚŚŽĨƚŚĞĐĞůůŵŽŶŽůĂǇĞƌ













Figure 10 - Uninfected MDA MB 468 cells. Stains show active cells (A), but no non-specific 
Sporo-Glo ? binding is observed (B). Low confluency suggests cells may have sloughed off (C). 








Figure 11 ʹ RKO cell line with single C. parvum. Here, an extremely faintly labelled Sporo-
'ůŽ ?ƌĞŐŝŽŶ ? )ŝƐǀŝƐŝďůĞ ?ďƵƚƚŚŝƐƐŚŽǁƐŶŽĐŽƌƌĞƐƉŽŶĚŝŶŐW/ƐƚĂŝŶ ? ) ?DŝƚŽƚƌĂĐŬĞƌ ?ƐŝŐŶĂů
(B) is barely detectable. A faint outline is visible in the DIC image (D). Region appears in 
contact with host nucleus (E). 
Figure 12 - Uninfected RKO cells. Cells show a similar level of detachment to the infected cells, 
and also show low mitochondrial activity (A, C). No Sporo-Glo ? labelling is present (B).  




This cell line is ĚĞƌŝǀĞĚĨƌŽŵĂƵŬĞ ?ƐƚǇƉĞĐŽůŽƌĞĐƚĂůĂĚĞŶŽĐĂƌĐŝŶŽŵĂ ?^ĐƌĞĞŶŝŶŐŽĨƚŚĞƐĞĐĞůůƐ
showed evidence of oocysts or type II merozoite development within host cells (Fig. 13). Parasite 
labelling is faint, and there is a relatively low level of infection in this cell line, but the presence of 
type II meronts or potentially oocysts means that the complete life cycle may be present. 










Figure 14 - Uninfected SW480 cells. Cells appear active (A). Bleed through or potential non-
specific binding is visible in the Sporo-Glo ? channel (B), but this may be due to air trapped 
under the slide (C).  
Figure 13 - SW480 cells with three parasites visible. Two type II meronts (Me II) are present 
to the right, shown with four nuclei (white arrows) in the DAPI field (A) along with an 
intracellular stage (In) which is difficult to identify. Sporo-'ůŽ ?ƐŝŐŶĂů ? )ŝƐĨĂŝŶƚ ?ďƵƚĂƉƉĞĂƌƚŽ
occupy the vacuoles seen with Mitotracker ? (B) Outlines of the Sporo-'ůŽ ?ůĂďĞůůĞĚƌĞŐŝŽŶƐ
are visible with DIC (D).  




A ƵŬĞ ?ƐƚǇƉĞĐŽůŽƌĞĐƚĂůĐĂƌĐŝŶŽŵĂ ?dŚŝƐĐĞůůůŝŶĞǁĂƐĚĞƌŝǀĞĚĨƌŽŵƚŚĞƐĂŵĞƉĂƚŝĞŶƚĂƐƚŚĞ^ t ? ? ?
cell line, a year later. This cell line was capable of supporting the C. parvum infection to some 
degree, but at a low level. This cell line also exhibited fast growth, with a tendency to become 
confluent within a few days. Intracellular stages were few in number, and those that were detected 
all appeared to be trophozoites (Fig. 15). Non-specific binding of the uninfected control means that 
this may not be C. parvum (Fig. 16) but the presence of a separate DAPI stain and the visible stage 







Figure 15 ʹ SW620 cell infected with C. parvum trophozoite. Single Sporo-'ůŽ ?ůĂďĞůůĞĚ
region (C) is visible (a trophozoite, white arrow). This is outlined by an area devoid of 
mitochondrial activity (B), the DAPI staining (A) reveals a faint outline of a distinct nuclei 
separate from the host nuclei. Parasite occupies vacuole like srea (E). Separate parasite is 
visible with DIC (D). 





A semi-adherent colorectal cell adenocarcinoma. No observable intracellular stages were detected, 
however one unique Sporo-'ůŽ ?ƐƚĂŝŶŝŶŐƐƚĂŐĞǁĂƐǀŝƐŝďůĞ (Fig. 17). Majority of monolayer was 
detached/in medium by the end of the week, making tracking life cycle progression difficult.  
Figure 16 - Uninfected SW620 cells. Cells are at high density (A, C) and show some evidence of 
non-specific Sporo-Glo ? labelling (B).  






A non-small cell lung cancer, which showed a moderate level of infection (Fig. 18 (a)). Parasites 
appear to occupy a vacuole area within the host cell devoid of mitochondria (Fig. 18 (b)). 
Development of stages is intracytoplasmic. Stages seen appeared limited to the asexual cycle, with 
no gamont stages being visible, although the presence of potential type II meronts (Fig. 18 (b)) 
suggests that sexual stages may be present in the culture. Uninfected cells shown in Fig. 19. 
 
 
Figure 17 - Potential extracellular stage detected in COLO-320 cell culture. COLO-320 cells 
show weak Mitotracker ? staining (B), indicating probable death of monolayer, along with the 
low confluency (D). Stage intensely stains with Sporo-Glo ? ? )ĂŶĚƉŽƐƐĞƐƐĞƐĂŶƵŶƵƐƵĂů
morphology, appearing similar in membrane structure to a dividing cell, however showed no 
ƵƉƚĂŬĞŽĨW/ƐƚĂŝŶ ? )ŽƌDŝƚŽƚƌĂĐŬĞƌ ? ? ) ?/ ? )ƐŚŽǁƐƐŽŵĞŝŶƚĞƌŶĂůŽƌŐĂŶŝƐĂƚŝŽŶĐĂŶďĞ
discerned. A rounded, nucleus like structure appears visible within the cytoplasm, (D, E) with 
additional smaller structures visible clustered around it.  









Figure 18 (b) ʹ Two type II meronts 
within a H2228 cell, circled area of 
Figure 18 (a).  Parasites appear to be in 
contact (white arrow, B) and occupy a 
vacuole lacking mitotracker signal. 
Stages are visible with DIC (A). 
Figure 18 (a) ʹ Infected H2228 monolayer. Sporo-'ůŽ ?ůĂďĞůůŝŶŐ ? )ƌĞǀĞĂůƐƐĞǀĞŶƉĂƌĂƐŝƚĞƐŝŶ
ƚŚĞĨŝĞůĚ ?DŝƚŽƚƌĂĐŬĞƌ ?ƐŝŐŶĂůƌĞǀĞĂůƐǀĂĐƵŽůĞůŝŬĞĂƌĞĂƐŽĐƵƉŝĞĚďǇƚŚĞƉĂƌĂƐŝƚĞƐ ?W/ƐŝŐŶĂů
(A) reveals brighter signal in areas labelled with Sporo-'ůŽ ? ?/ŝŵĂŐĞ ? )ƐŚŽǁƐĨĂŝŶƚ
outlines of parasites. Circled area shown in Fig. 18 (b). Stages here appear to be trophozoites 
and meronts, with no sexual stages visible. 





A lung adenocarcinoma showing several parasites present across the observed fields (Figs. 21 & 
22). In this cell line, multiple parasites within a single cell was commonly observed (Figs. 20 & 22). 
Observed stages included a high level of gamonts and type II meronts, along with the developing 
zygotes (Fig. 20) and an oocyst (Fig. 21). Uninfected cells shown in Fig. 23. 
Figure 19 - Uninfected H2228 cells. Mitochondrial activity (A) and attached cells (C) visible, 
some background activity in Sporo-Glo ?channel (B), but rounded bodies seen in infected cells 
not present.  
Figure 20 ʹ Infected HCC4006 cells. Sporo-'ůŽ ?ƐŝŐŶĂů ? )ƐŚŽǁƐŵƵůƚŝƉůĞƉĂƌĂƐŝƚĞƐƉƌĞƐĞŶƚŝŶ
ƚŚĞĨŝĞůĚ ?DŝƚŽƚƌĂĐŬĞƌ ?ƐƚĂŝŶŝŶŐ ? )ĂƌĞĂƐůĂĐŬŝŶŐƐŝŐŶĂůǁŚŝĐŚĐŽƌƌĞƐƉŽŶĚƚŽƚŚĞ Sporo-'ůŽ ?
labelled areas (E). DAPI staining (A) shows discrete regions corresponding to these areas. DIC 
imaging (D) shows outlines of the parasite are slightly visible (black arrows). Mostly sexual 
stages are present; meronts II (Me II), microgamonts (Mi), developing zygotes (Zy). 














Figure 21 ʹ Infected HCC4006 cells. Sporo-'ůŽ ?ƐŝŐŶĂů ? )ƐŚŽǁƐŵƵůƚŝƉůĞƉĂƌĂƐŝƚĞƐƉƌĞƐĞŶƚ
(white arrows). DŝƚŽƚƌĂĐŬĞƌ ?ƐƚĂŝŶ ? )ƐŚŽǁƐĂƌĞĂƐůĂĐŬŝŶŐƐŝŐŶĂůǁŚŝĐŚĐŽƌƌĞƐƉŽŶĚƚŽƚŚĞ
Sporo-'ůŽ ?ůĂďĞůůĞĚĂƌĞĂƐ ? ) ?W/ƐƚĂŝŶŝŶŐ ? )ƐŚŽǁƐĚŝƐĐƌĞƚĞƌĞŐŝŽŶƐĐŽƌƌĞƐƉŽŶĚŝŶŐƚŽƚŚĞƐĞ
areas. DIC imaging (D) shows outlines of the parasite are slightly visible (black arrows). Present 
are trophozoites (Trop) meronts II (Me II), macrogamonts (Ma) and a developing oocyst (Oo) 
(E). 







Figure 23 - Uninfected HCC4006 cells. Cells are attached (C) and show mitochondrial activity 
(A). Some background Sporo-Glo ? activity (B), but the corresponding parasite nuclei and 
vacuoles seen in infected cells are absent.  
Figure 22 - Three parasites within a single HCC4006 cell. Sporo-'ůŽ ?ƐƚĂŝŶĞĚƌĞŐŝŽŶƐ ? )
occupy vacuoles (B, E) and have discrete nuclei (A) indicating likely type II meronts. Stages 
visible with DIC (D). 
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3.2 Presence of C. parvum DNA  
The presence of extracellular oocysts in the culture medium was tested using PCR with C. parvum 
specific primers, SB012. SB012 do not target specific DNA regions, but are  “RAPD ? (random 
amplification of polymorphic DNA). Initially, primers specific for C. parvum Hsp70 were tried, but 
showed a high level of non-specific binding. While optimisation using these primers was attempted, 
the SB012 primers provided far clearer DNA bands when resolved on agarose gels. The PCR reaction 
was tested on all samples. Bands were generated at approximately the expected band size (433 bp), 
with purified C. parvum DNA acting as a positive control (Figs. 26 & 27). Bands were generated in 
at least one sample from the following cell lines; BT-474, EFM-19, MDA MB 468, HCC4006, COLO-
320, SW480 and SW48. All of these stages showed some instance of intracellular infection, with the 
exception of COLO-320, which showed an unusual stage (see section 3.1) and SW48, where no 
stages were visible. Bands were absent in samples which showed no stages, and in samples were 
few stages were present; CAMA-1, H2228, HCC827, SW620, IGR-39, RKO and LS-174T.  
As the primers used do not target a specific DNA sequence and are RAPD primers (targeting random 
regions of the C. parvum genome) they were tested for non-specific binding to human DNA. Human 
small ribosomal RNA coding DNA was amplified, showing successful DNA extraction and 
polymerisation (Fig. 28). Using the SB012 primers, no off-target binding was detected (Fig. 28). Due 
to time constraints, not every cell line could be tested for non-specific amplification, but the lack of 













Figure 26 - PCR of media from 24 well 
plate infections, SB012 primer set. 2 % 
agarose gel stained with ethidium 
bromide. C. parvum DNA present in one 
of the BT-474 samples, three of the 
EFM-19 samples, one of the MDA-MB-
468 samples, two of the HCC4006 
samples, three of the SW48 samples 
and one of the SW480 samples. Bands 
generated at expected size (~450 bp). 
Secondary band visible at ~300 bp, the 
source of which is unclear, potentially 
due to a similar sequence elsewhere in 
the genome.  Some samples were lost 
due to lids opening in storage, meaning 
only three samples were available for 
testing (CAMA-1, COLO-320, H2228, LS-
174T and RKO). Positive control (+) is 
extracted stock oocyst DNA, negative (-) 
is DEPC treated water. 





Figure 27 - PCR of UKF-NB-3, EFO-21 and EFO-27 media, SB012 primer set. All wells show no 
detectable C. parvum DNA. Positive control - extracted C. parvum oocyst DNA.  
Figure 28 - Extracted DNA of four cell lines tested for non-specific SB012 primer 
amplification. Positive control (left hand lanes) of human 18srRNA primers. Right hand lane 
SB012. No non-specific binding is detected.   
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3.3 Glucose Consumption 
Due to C. parvum relying on the host cell for many of its metabolic requirements, the effect of 
infection on the rate of glucose consumption was tested. Glucose levels were compared daily in 
infected and uninfected COLO-680N and HCT-8 cells. Four wells were tested under each condition, 
averages were taken from the four readings and plotted (Fig. 29). There was no difference in the 
rates of glucose consumption between infected and uninfected COLO-680N cells. There were large 
differences in the rate of glucose consumption between the cell lines, with HCT-8 depleting the 
medium glucose within 2 days of infection, with a higher initial rate of consumption, while COLO-
680N retained glucose in the medium for a week after infection (Fig. 29). These differences were 
reflected in the growth pattern of the cells, with HCT-8 growing as multiple layers of cells, which 
was not observed in the COLO-680N cell line.  
 
Figure 29 - Glucose Consumption of infected and uninfected COLO-680N cells and HCT-8 
cells. Rate of consumption was calculated as the difference in glucose consumption since the 
previous reading over hours since the last reading. Error bars are SD of four experiments. In 
COLO-680N cells there is no difference between infected and uninfected cells. Glucose 
consumption initially rises, likely due to growth of monolayer and subsequently decreases, 
possibly due to reduced growth rate as cells reach confluency. In HCT-8 cells glucose 
consumption remains high initially in infected cells but drops off. Media of all HCT-8 wells was 
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3.4 Sub-Infections  
Four cell lines were selected for culture in T-25 flasks, to investigate whether infection can not only 
be maintained but can produce oocysts which can be passaged between cell monolayers. MDA-MB-
468, SW480, EFM-19 and HCC4006 were chosen as they demonstrated presence of meronts II and 
evidence of intracellular sexual stages (except SW480, but the presence of meronts II and 
detectable C. parvum DNA was deemed acceptable (sections 3.1 and 3.2 respectively) with 
fluorescent microscopy (see section 3.1). 2.8 x 105 oocysts were added to low confluency T-25 flasks 
(approximately 20 % confluency), incubated overnight followed by removal of unexcysted oocysts. 
Weekly, C. parvum in the medium 
was pelleted and transferred to a 
freshly seeded T-25 flask for three 
weeks. All cell lines provided a 
return over the initial inoculum. 
MDA-MB-468 and EFM-19 had 
counts of 1.36 x 105 and 1.44 x 105 
oocysts per mL respectively (net 
production 0.8 x 105 and 0.9 x 105 
respectively), equating to around 
a 1.5 x net return of oocysts. 
SW480 had counts of 1.8 x 105 
oocysts per mL (net 1.2 x 105) provided a net gain of double the initial inoculum while HCC4006 
provided 5.8 x 105 oocysts per mL (net 5.2 x 105), a nine-fold net increase over three weeks (Fig. 
30).  
3.3 Bioreactor 
To establish an in vitro system which enables long term culture and convenient harvesting of 
oocysts, a miniPERM® SM bioreactor was inoculated with 36.8 x 106 COLO-680N cells and 18.4 x 106 
treated C. parvum oocysts. The bioreactor was maintained for 13 weeks and produced oocysts 
continuously. Medium glucose reduced at a rate of approximately 1.4 mmol/L per day, and medium 
was replaced weekly. Microscopy of unfixed samples showed a thin walled oocysts undergoing 
excystation and releasing a sporozoite 10 weeks after inoculation implying the auto-infective cycle 
enabled continuous propagation (Fig. 33). Staining of samples with Crypt-a-'ůŽ ? antibody 
(antibody specific for oocysts) showed production of thick walled oocysts which appeared fully 
intact, with excysted oocysts also present (Fig. 32). Enumeration of oocysts showed a fairly constant 
level of 1x 106 oocysts per mL (Fig. 31) across all the observed months. In order to assess the 
Figure 30 ʹ Counts of oocysts per mL from sub-infection 
experiments. Shown are the results of average counts of 
three T-25 flasks.  
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infectivity of these oocysts, HCT-8 and COLO-680N monolayers were infected following a standard 
infection protocol with 7 x 104 oocysts after a three and seven day incubation respectively. All 
tested time points yielded infection, with representative images of oocysts harvested three months 
post infection (p.i.) are shown in Fig. 34. In both of these cell lines, multiple life cycle stages can be 
seen, indicating infectious oocyst production. COLO-680N monolayers showed a higher level of 





































Figure 31 ʹ Bar chart of oocyst counts from monthly bioreactor 
harvests. Single haemocytometer counts, levels remain fairly constant 
of at least 1 x 106 oocysts per mL. 
Figure 32 ʹ Oocysts from bioreactor 1 
month post infection. Varying stages of 
excystation are present Crypt-a-'ůŽ ?ƐƚĂŝŶ
(green) with DAPI (blue).  





Figure 33- Unfixed sample of thin walled 
oocyst (Oo) with DIC microscopy. A 
sporozoite (Spo) stage appears to be 
excysting from the top, and was seen 
moving away from the oocyst.  
Figure 34 - Reinfection of COLO-680N cells (A, B) and HCT-8 cells (C, D) with bioreactor 
produced oocysts, third month harvest. Parasites visibly labelled with Sporo-'ůŽ ? ? ?ǁŚŝƚĞ
arrows). Outlines are slightly discernible in COLO-680N cells (A) but not in HCT-8 cells (C), as 
cells have grown over infected cells. 
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4.0 Discussion  
17 cell lines were tested for their ability to propagate infection, with 10 displaying some evidence 
of intracellular C. parvum development (Table 4). Owing to the presence of the complete life cycle 
and detectable C. parvum DNA, four of these cell lines (EFM-19, MDA MB 468, SW480 and HCC4006) 
were used to establish sub-infections of cell monolayers, and after three weeks all provided a net 
gain of oocysts. HCC4006 provided the highest yield, with a nine-fold return on the initial inoculum. 
In addition, a small scale bioreactor was established using COLO-680N cells, and produced 
infectious oocysts for 13 weeks. The development of C. parvum in multiple cell lines should not be 
considered surprising considering the number of cell lines which have been previously reported as 
maintaining the life cycle, but as studies have shown previously (Arrowood 2002; Hijjawi 2010; 
Karanis et al. 2011) not every cell line described here was capable of supporting the entire life cycle. 
The fluorescent microscopy images shown here suggest that, for the majority of the life cycle, C. 
parvum remains in an intracellular location. Apparent intracellular development has been observed 
previously in other cell lines, for example in macrophages and human foetal lung cells (Beyer et al. 
2000; Current et al. 1984). It cannot be concluded that this development is intracytoplasmic 
however, as microscope slide preparation has the potential to displace cellular structures, and 
scanning electron or confocal microscopy will be required to confirm the parasites location. The 
development across multiple cell lines implies the surface markers required for invasion are 
expressed to some extent across multiple tissues, or that binding is relatively non-specific. Other 
investigators have hypothesised that initial attachment and invasion relies on specific surface 
proteins being expressed on the host cells, while dissemination to secondary sites is due to the 
overexpression of adhesion and invasion proteins on the parasite (Hijjawi 2010). These proteins 
allow binding to non-specific surface ligands on host surface cells, allowing invasion. The PCR results 
show that not all cell lines which show intracellular development produce enough of the parasite 
to be detectable, which requires 100 oocysts per well to give a positive result (resuspended in 50 
µL = 2 oocysts per µL, diluted one in ten to give 0.2 µL, 5 µL PCR reaction template = 1 oocyst). Few 
of the cell lines were capable of producing this, suggesting that, although invasion and entry into 
the asexual phase of the life cycle can occur, both high numbers of C. parvum and entry into the 
sexual stages is a rare occurrence. Not all samples tested positive when DNA was detected, implying 
there is considerable variation in cell lines ability to propagate infection. An alternative explanation 
is that C. parvum was lost during processing in some samples.  
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Table 4 - Summary of cell line performance  
Cell Line Cell Type Detectable C. 




BT-474 Invasive ductal 
carcinoma 
One of four samples Asexual Stages 
CAMA-1 Breast carcinoma No Asexual Stages, Oocysts 
COLO-320 Dukes' type C, colorectal 
adenocarcinoma 
One of three samples Extracellular-like stage  
EFM-19 Breast carcinoma  Three of four samples Complete Life Cycle  
EFO-21 Ovarian 
cystadenocarcinoma 
No None  
EFO-27 Ovarian mucinous 
adenocarcinoma 
No None  
H2228 Non-small cell lung 
cancer 
(adenocarcinoma) 
No Complete Life Cycle 
HCC827 Lung adenocarcinoma No None 
HCC4006 Lung adenocarcinoma  Two of four samples Complete Life Cycle 
IGR-39 Melanoma No None 
LS-174T Dukes' type B,colorectal 
adenocarcinoma 
No None 
MDA-MB-468 Breast adenocarcinoma One of four samples Complete Life Cycle 
RKO Colon carcinoma  No Asexual Stages 
SW48 Dukes' type C, grade IV, 
colorectal 
adenocarcinoma 
Three of four samples None 
SW480 Dukes' type B, colorectal 
adenocarcinoma 
One of four samples Complete Life Cycle 
SW620 Dukes' type C, colorectal 
adenocarcinoma 
No Asexual Stages 
UKF-NB -3 Neuroblastoma No None 
 
The four tested breast cancer cell lines all showed some degree of C. parvum intracellular 
development. BT-474 and CAMA-1 were not worth pursuing further, due to a lack of sexual stages 
and detectable C. parvum DNA. The EFM-19 and MDA-MB-468 cell lines showed the complete C. 
parvum life cycle after a week, with EFM-19 having multiple samples test positive with PCR, while 
only one of the MDA MB 468 samples did. Both cell lines were selected for the passaging 
experiment and yielded 1.44 x 105 and 1.36 x 105 oocysts respectively, a net 1.6 and a 1.4 fold return 
in yield. There is a single reported instance of C. parvum development in breast cancer derived cells, 
with Upton reporting development in the BT-549 (breast infiltrating ductal carcinoma) cell line. The 
reported yields were relatively low, a quarter of the yield of HCT-8 cells (Upton, Tilley and Brillhart 
1994). The breast cancer cell lines reported here are more promising, maintaining the complete life 
cycle for the whole week and may be suitable for further development.     
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Three types of cell line have not been reported previously; melanomas, neuroblastomas and 
ovarian adenocarcinomas. The melanoma cell line IGR-39 and the neuroblastoma cell line UKF-NB-
3 both failed to provide any detectable infection with microscopy or PCR. This may not be 
surprising, considering the fast growth of both of these cell lines, and their morphology, which is 
far from that of the ileum, with cells exhibiting long projections similar to neurons. The two ovarian 
cancers, EFO-21 and EFO-27 also showed no intracellular development or detectable parasite DNA. 
Development has been previously observed in an endometrial carcinoma derived cell line 
(Rasmussen et al. 1993), but not ovarian cystadenocarcinomas or mucinous adenocarcinomas.    
Of the six colorectal cell lines tested, only SW480 gave observable sexual stages after a week, with 
the others exhibiting either no entry into the sexual stages or no visible parasites. SW480 provided 
a higher yield than the breast cancer cell lines during the passaging experiments, providing double 
the initial inoculum. SW48 showed detectable DNA in three of four samples, but no intracellular 
stages were observed. This implies initial invasion was successful but subsequent rounds of 
replication may have failed. Previously, development in LS 174T has been described as being a 
quarter of that of HCT-8 (Upton 1994) after 68 hour incubations; here longer incubation does not 
provide higher levels of C. parvum, with no intracellular stages present and no C. parvum  DNA 
detectable with PCR. The COLO-320 cell line, despite the low yield, gave rise to a unique staining 
stage not observed in other cell lines. This large region stained with Sporo-Glo ? antibody, but 
showed no DAPI staining. Given the single occurrence of this stage, it is difficult to determine its 
nature. While investigators have previously described extracellular stages of C. parvum (Hijjawi et 
al. 2001; Hijjawi et al. 2004; Rosales et al. 2005), this stage bears little resemblance to them, with 
arguably a slight resemblance to one observed in mice by (Hijjawi et al. 2002). If this stage is a 
parasite, it may be undergoing the binary fission process observed previously (Borowski et al. 2010), 
however the exact nature of this stage, and whether it is even the parasite, remains to be seen. The 
use of semi-adherent cells for C. parvum culture requires additional steps during routine cell 
passage and makes observing the parasite life cycle difficult, making the COLO-320 cell line 
unsuitable for routine infection studies. Colorectal cell lines have been the cell line of choice for in 
vitro C. parvum studies, notably the cell lines Caco-2 and HCT-8 which have been used by numerous 
investigators (Upton, Tilley and Brillhart 1994; Hijjawi et al. 2001; Woods et al. 2007; Morada et al. 
2016; DeCicco RePass et al. 2017) for the last thirty years. The attraction of the HCT-8 cell line is the 
fast turnaround of 3 days (Slifko 1999, Upton 1994) the ability of aged monolayers to support 
infection (Sifuentes et al. 2007) along with C. parvum ?ƐĂďŝůŝƚǇƚŽĐŽŵplete its complete life cycle in 
these cells (Hijjawi et al. 2001). These cells are prone to overgrowth and die rapidly; previous 
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experiments have shown that HCT-8 shows inferior infection compared with COLO-680N, which 
supported far higher infection levels for eight weeks (Miller et al. 2017). 
Two of the lung cancers tested here supported infection, with H2228 showing potential type II 
meronts but not observable sexual stages, or detectable C. parvum DNA. HCC4006 demonstrating 
the complete life cycle and gave detectable C. parvum DNA in two of four samples. Following this, 
the T-25 passaging over three weeks showed HCC4006 produced nine times the initial inoculum of 
parasites. The only previous descriptions of development in lung cell lines were human foetal lung 
described in 1984, the first cell line to support complete development (Current et al. 1984), and the 
MRC-5 cell line (Dawson et al. 2004). While efforts were made to compare COLO-680N and 
HCC4006 performance, unfortunately this was not possible within the time frame, given the change 
to fresh oocysts during the final two months of the project, which were used for the passaging 
studies, while COLO-680N cells were infected with older (> 6 month old) oocysts, which would have 
likely skewed the results in favour of HCC4006.        
While this study shows that numerous cell lines can support infection, the mechanisms behind a 
cell lines success, or lack thereof, are still poorly understood. Characterising the cell lines described 
here was not realistic within the given time frame, but extensive characterisation is essential to gain 
insight into host-pathogen interactions and to develop more efficient in vitro culture methods. One 
avenue is the examination of protein expression and comparing infected and uninfected cell lines. 
While Western blotting is often used to characterise pathways in cancer cell lines, the use of single 
antibodies for each protein which may be impacted by C. parvum would be both costly and time 
consuming. An alternative approach is a mass spectrometry based approach, which can provide 
data on both a small scale and at the proteome level, including data on protein-protein interactions 
(Aebersold et al. 2003). Mass-spectrometry analysis has already been conducted on the proteome 
of various life cycle stages of Plasmodium falciparum (Lasonder et al. 2002). One alternative is the 
use of microarrays or RNA-sequencing of infected cells. The microarray approach has been used 
previously to demonstrate altered gene expression during infection (Liu et al. 2009). We may 
speculate as to the reasons the cell lines described here have or have not worked. Those which 
failed to show any infection (IGR-39, UKF-NB-3, LS-174T, EFO-21, EFO-27 and HCC827) are, with the 
exception of HCC827, small cells with a generally fast growth rate. The fast growth rate may not 
allow C. parvum to divert the necessary nutrients to itself, causing parasite death or arrest of the 
life cycle. The size of cells may also have an impact on invasion. The seeding density was altered for 
smaller, faster growing cells, which may lead to sporozoites having difficulty identifying a suitable 
host cell. Taking into account the shorter motility tails left by C. parvum sporozoites (Wetzel et al. 
2005), the distance travelled to locate a host cell may be crucial in determining success of infection. 
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This comes with its own problems, as a higher number of host cells also means confluency will be 
reached sooner and that vital medium components are depleted at a higher rate. Two cell lines 
which showed no infection do not share features of the others; LS 174T and HCC827. Both of these 
cell lines grow at a similar rate and form similar structures to COLO-680N, H2228 and HCC4006 cells, 
with large spaces present between cells, measuring several hundred microns across. Morphology 
and growth rate alone are not enough to determine the success of infection, as the critical invasion 
process is likely key to supporting the parasite in culture, and will rely on complementary ligand 
expression of host markers to sporozoite adherence factors (Hijjawi 2010). As several cancers 
exhibit altered glycosylation of membrane proteins (Hakomori 1996), it is likely that lectins on C. 
parvum may show altered binding and subsequent invasion. Following the initial invasion, C. 
parvum relies on its host for the synthesis of a wide number of metabolites and precursors it cannot 
synthesise de novo (Abrahamsen et al. 2004; Ehrenman et al. 2013; Miller et al. 2017, Panagos, et 
al. 2017). As exhibited by the glucose consumption experiment, rapid glucose consumption may 
indicate a Warburg metabolism in some cell lines. This is a shift from oxidative phosphorylation to 
substrate level phosphorylation seen in certain cancers, which may have negative impacts on 
parasite growth, particularly if C. parvum relies on mitochondrial products, such as iron sulphur 
clusters or steroids, the latter of which is believed to be a key component of the oocyst wall (Harris 
et al. 1999; Liu et al. 2010; Jenkins et al. 2010). Metabolomics of infected and uninfected cell lines 
using mass spectrometry or NMR is already being investigated (Miller, Panagos, et al. 2017) will 
enable a more thorough understanding of C. parvum life cycle, metabolism and potentially identify 
areas which can be exploited as vaccine targets.  
In this study, all slides were visualised at a single time point, which does not provide information 
regarding the progression of the life cycle and the timing of appearance of different life cycle stages. 
While initial processes can be observed with light microscopy, i.e. the inoculation of oocysts and 
the excystation process, further tracking of life cycle stages is extremely difficult. While the single 
time point approach is suitable for screening cell lines, true parasite growth patterns in any of these 
cell lines will require wither multiple time point replicates or the use of live cell imaging, such as 
ƚŚĞ/ŶĐƵǇƚĞ ?ƐǇƐƚĞŵ ?tŝƚŚĞŶĚƉŽŝŶƚĂƐƐĂǇƐ ?ŝŶĨĞƌĞŶĐĞƐĐĂŶďĞŵĂĚĞŽĨƚŚĞŝŶŝƚŝĂůŝŶĨĞĐƚŝŽŶĐŽƵƌƐĞ ?
The focus detection method of assessing parasite viability relies on the parasite life cycle forming 
secondary infections as a result of merozoite release from type I meronts, which are generated 
from an initial sporozoite invasion (Slifko et al. 1999). Real-time data would provide information of 
both early invasion and the intracellular replication and progression through the life cycle. It would 
also allow developmental monitoring of previously described extracellular stages described by 
others (Hijjawi et al. 2004; Rosales et al. 2005) and the stage observed in the COLO-320 cell line. 
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The bioreactor system described herein is the first to use a fixed wall rotating bioreactor for culture 
of the parasite for over three months. Previously, a similar system was used with HCT-8 cells grown 
on porcine mucosal grafts (Warren 2008) however infection stopped completely after 96 hours. 
Our current system was maintained for a total of 13 weeks, with oocysts being present in every 
harvest. Our system differs in the use of a single cell type and a single inoculum, while many other 
protocols using 3D culture use a mixture of cell types (DeCicco RePass et al. 2017) or require 
periodical replenishment of host cells (Morada et al. 2016). The advantages of the approach 
described here are a lower cost and a far less labour intensive system. Oocysts produced appeared 
to be both thin and thick walled, which is likely the reason for continued propagation of the system. 
Thick walled oocysts could be observed via fluorescent microscopy, while thin walled oocysts could 
be seen in the unfixed slides undergoing excystation. As thin walled oocysts are extremely delicate 
and tend to rupture/excyst when handled (Current et al. 1984) the preparation for microscopy likely 
caused this. Within the bioreactor, the continuous rotation likely induced the excystation/rupture 
of thin walled oocysts, allowing the life cycle to begin anew.     
 The system relies on a single inoculum of treated oocysts, however for the first few weeks 
of culture the production of oocysts is debatable, as it is conceivable that extracted oocysts are 
simply inoculated oocysts which have not undergone development. After the first month harvest 
the number of parasites per millilitre had increased over the initial inoculum, indicating 
multiplication within the bioreactor. In addition, the infections performed with this system yielded 
a high level of infection in multiple cell lines, with oocysts being used three months after the initial 
inoculation producing infection. While the argument could still be made for the initial oocyst 
inoculum causing the infection, a previous study of oocyst infectivity showed that after one week 
of storage oocysts kept at 35 °C were only infective to two of ten mice, with no infection after longer 
storage times (Fayer et al. 1998). While a small portion of oocysts may survive long enough to retain 
infectivity, the high level of infection observed in these cell lines indicates the harvested oocysts 
were produced within a week of harvesting, implying continuous generation of oocysts. During the 
reinfection studies it is possible that motile infective stages (sporozoites and merozoites) were 
transferred to the monolayer as opposed to oocysts. In order to avoid this problem, samples were 
stored at 4 °C for at least a week prior to infection. Observations by Petry and colleagues have 
shown that sporozoites are rendered uninfectious if they fail to invade a host within 24 hours when 
kept at 37 °C (Petry et al. 2009). The reduced temperatures used here have not been tested on 
purified sporozoites, however given the lack of protective oocyst wall and limited amylopectin 
reserves (Fayer 1994) it seems unlikely that these stages can persist at 4 °C for prolonged time 
periods whilst retaining infectivity. The ability of oocysts to produce an infection in cultured 
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monolayers shows their infectivity in vitro. Further assessments of parasite viability would involve 
propidium iodide staining in combination with DAPI, which differentiates between viable and total 
oocysts. Infections with mice models would also confirm the infectivity of the produced oocysts in 
vivo. Another enumeration method is the focus detection method (Slifko et al. 1999), which 
measures infective oocysts based on cell invasion. In addition, enumeration may be achieved by 
qPCR, a method used by other investigators to quantify parasites (Zhang et al. 2009; Koh et al. 
2013), and flow cytometry may allow for enumeration and assessment of infectivity (Foster et al. 
2003). 
The trialled T-25 sub-infections show that oocysts can be both produced and maintained in cell lines 
without the need for excystation treatment between passages. The production of thin-walled 
oocysts, as in the bioreactor, is likely the reason for this, allowing auto-infection of the culture. 
Previous descriptions of culture in traditional tissue culture flasks have utilised HCT-8 cells, however 
the described methods passaged infected cells directly between flasks, and had the medium 
changed every 2-3 days (Hijjawi et al. 2001). The methods described herein utilised direct passage 
of infectious extracellular stages, and may also involve the passage of merozoites between flasks. 
In addition, no fresh medium was added during except during passaging, which has been reported 
as resulting in higher numbers of extracellular stages and intracellular stages in HCT-8 cells when 
used with medium supplemented with CaCl2 and MgCl2 at 1 mM (Perez Cordón et al. 2007). Aged 
monolayers alone do not seem to promote invasion (Sifuentes et al. 2007), so any efforts to develop 
such a protocol will likely require supplementation of media prior to ageing experiments. In the 
future, both media changes and aged cells may be trialled and compared, and if in conjunction with 
real time visualisation techniques discussed earlier, a better idea of optimal passaging and seeding 
times may be established.           
 The yields of HCC4006 show a high return on the initial inoculum, and future development 
may enhance this yield. Numerous investigators have reported that media supplements can greatly 
improve parasite yield (Upton et al. 1995; Woods et al. 2007; Perez Cordón et al. 2007). While this 
was not trialled here, it is likely that media supplements and the base media were having an effect 
on the yield, if not the entire invasion process. Three of the cell lines used in the subculture 
experiments used IMDM with 10 % FBS as the base medium, while HCC4006 used RPMI 1640 with 
10 % FBS. IMDM contains more glucose than RPMI-1640, which may encourage cell proliferation. 
To ascertain the effects of the base media, cell lines could be adapted to the medium before being 
infected. It seems likely that this would allow for better selection of base media to use for respective 
cell lines. The yields reported here are modest by comparison to the reported hollow fiber system 
(1 x 106 oocysts per mL compared with 1 x 108 oocysts per mL), (Morada et al. 2016) but here solely 
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base medium with no supplements was used. The hollow fiber system uses a base MEM medium 
with 15 mM HEPES buffer, described by (Upton, Tilley and Brillhart 1994) in the tubes, while 
mediumcirculating the main lumen space requires additional additives; 20 mg/mL glutathione, 
taurine, betaine and cysteine were all included, along with a lipid mixture (composed of 1.5% 
deoxycholate, 6.7 mg/mL oleic acid, 10 mg/mL phosphocholine, 1.6 mg/mL a-linolenic acid, 6.8 
mg/mL eicosapentaenoic acid, 2mg/mL docosahexaenoic acid, 18 mg/mL cholesterol) and requires 
degassing of media (Morada et al. 2016). In addition, a set-up time is required of 11 days, and the 
weekly medium change requires a full litre of medium. While the reported yields may be worth the 
investment, anecdotal reports suggest this method is not readily reproducible, and that the system 
is exceptionally prone to contamination. The system described here is at lower risk due to the 
simpler apparatus and fewer steps involving moving the bioreactor out of the incubator 
environment, and the low cost means this system may be adopted by other laboratories to 
routinely propagate C. parvum in vitro. By combining the bioreactor system with the high yield cell 
line HCC4006 and identifying a media composition which allows high yields of oocysts, the yields 
may rival those reported for the hollow fiber system, at a much lower cost and with less labour 
intensive maintenance.  
Moreover, recent focus has shifted from cell culture to axenic culture of C. parvum (Karanis et al. 
2011). With the reported success establishing the complete life cycle of the parasite in host cell free 
culture (Hijjawi et al. 2004), this system would avoid nearly all of the current problems associated 
with in vitro host cell culture, however, many groups have tried and failed to replicate these findings 
(Woods et al. 2007; Girouard et al. 2006). While the DNA replication of C. parvum has been reported 
by several groups, there is a lack of images demonstrating the complete life cycle in axenic culture. 
Also, there is considerable debate as to the identity of life cycle stages seen by different groups  
(Hijjawi et al. 2004; Woods et al. 2007; Karanis et al. 2008; Petry et al. 2009; Koh et al. 2013; Karanis 
et al. 2011) by light microscopy, confocal microscopy and electron microscopy. The axenic culture 
reported by (Hijjawi et al. 2004) included images of extracellular stages which had not been 
observed previously, and many of the described stages of the normal life cycle have been identified 
by others as being yeast and other contaminants (Woods et al. 2007). In addition, the development 
of the extracellular stages described by Hijjawi and Rosales have not been seen by other groups 
(Karanis et al. 2011; Aldeyarbi et al. 2016a; Aldeyarbi et al. 2016b). A recent study validating the 
original axenic culture system reported the identification of some stages of the life cycle, however 
these were limited to the asexual stages (Yang et al. 2015) ?dŚĞĚĞƐĐƌŝďĞĚ ‘ŵĞƌŽǌŽŝƚĞƐ ?ƐŚŽǁƐŝŵŝůĂƌ
morphology to the aged sporozoites described by (Petry et al. 2009). Stages identified by other 
investigators as merozoites (Karanis et al. 2008) also have similar morphology.    
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Another recent paper demonstrated C. parvum DNA replication in a model biofilm system, and used 
confocal microscopy to demonstrate life cycle progression (Koh et al. 2013; Koh et al. 2014). The 
presented confocal images show little similarities to the stages identified during this study here and 
bear little similarity to the stages shown by (Aldeyarbi et al. 2016a). Identifying C. parvum stages in 
axenic culture remains difficult, as there is no widely agreed upon reference images with which to 
identify stages. The reports of multiplication in cell free systems mean these are a promising area 
for future development, and recently many investigators are reporting the multiplication of C. 
parvum in host cell free systems (Zhang et al. 2009; Koh et al. 2013). With the exception of 
(Aldeyarbi et al. 2016b), no investigators provide evidence of the complete life cycle being present. 
A recent paper describing the multiplication of C. parvum in an aquatic biofilm system claims to 
show type II meront development (Koh et al. 2013), however these stages, while similar to those 
observed by (Hijjawi et al. 2004), have been identified by others as fungal contaminants and debris 
(Woods et al. 2007). While it is conceivable that C. parvum has differing morphology in cell free 
systems, these stages are not the same as observed by (Aldeyarbi et al. 2016a), which show similar 
ultrastructure to in vivo stages. Description of multiplication in cell free culture observed by Zhang 
provides qPCR evidence of parasite multiplication and evidence of stages present with fluorescent 
microscopy, but the complete life cycle still appears absent (Zhang et al. 2009). While the 
replication of C. parvum has recently been observed in axenic culture with transmission electron 
microscopy (Aldeyarbi et al. 2016c; Aldeyarbi et al. 2016b; Aldeyarbi et al. 2016a), these stages and 
the development of oocysts has not been quantified. Adaptation of this system may be the first 
step toward axenic in vitro culture. For the moment, complete development in high numbers seems 
to be seen only in host cell culture, and will likely remain so until a better understanding of this 











In summary, the complete life cycle of C. parvum has been shown to occur in four of the tested cell 
lines, however there is still the problem of low yields in three of these. A cell line has been identified 
which can support the entire life cycle and produce a high yield of oocysts, the lung adenocarcinoma 
HCC4006. The HCC4006 cell line is a suitable candidate for further development owing to its ability 
to produce an increase over the initial inoculum of oocysts and its ability to survive for a week with 
no medium change in a single culture vessel. This cell line is generally user friendly, requiring a 
medium change once weekly and generally a weekly passage when seeded at a 1:4 split ratio. The 
establishment of a low cost bioreactor with a simple protocol will enable researchers to cultivate 
C. parvum continuously to supplement their commercial supplies, and further development of this 
system will enable higher yields to be generated. Productive and routine culture of C. parvum in 
vitro may be within reach, and by further developing cell lines with high potential such as COLO-
680N and HCC4006 and using them with low cost and simple 3D culture systems, a truly 
reproducible and long term system will enable in vitro harvesting of parasites at a level which can 
be used for experiments, and potentially enable the first maintenance of clonal C. parvum 
populations in vitro. While axenic culture is a tantalising prospect, for the foreseeable future it is 
likely that host cell culture will remain the only option for reproducible parasite propagation until 
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